InnovationsKapital: Latest News

companyNews - 21 February, 2010 - Jasper: Jasper Releases New Formal Verification Proof Kits For LPDDR1, LPDDR2, And DDR3

2010-03-10 12:29:28

MOUNTAIN VIEW, Calif. Feb. 21, 2010 Jasper Design Automation, provider of advanced formal technology solutions, today announced the availability of Proof Kits for LPDDR1 and LPDDR2, and DDR3 SDRAM. These Jasper Proof Kits are sets of properties, written in SystemVerilog, related to standard JEDEC interface protocols. Each Proof Kit includes a Formal Testplan providing detailed instructions on verifying DDR designs, plus properties for the protocol that the JasperGold® Verification System can prove against any design employing the standard. LPDDR solutions are experiencing high growth in mobile and embedded markets as demand for the low-power parts surges. "These new LPDDR and DDR3 Proof Kits both speed verification for these high-demand memories, and ensure conformance with industry standards," said Lawrence Loh, Jasper Vice President of Worldwide Applications Engineering. They join our existing Proof Kits for SDR, DDR and DDR2, and we continue to actively follow and support new standards as they emerge." Availability The new DDR Proof Kits are currently available as a chapter within Jasper Formal Testplanner, and provided at no additional charge to current licensees of Formal Testplanner. About Jasper Design Automation Jasper delivers industry-leading EDA software solutions for semiconductor design, verification, and reuse, based on the state-of-the-art formal technology. Customers include worldwide leaders in wireless, consumer, computing, and networking electronics, with over 150 successful chip deployments. Jasper, headquartered in Mountain View, California, is privately held, with offices and distributors in North America, South America, Europe, and Asia. Visit www.jasper-da.com to reduce risks; increase design, verification and reuse productivity; and accelerate time to market. Jasper Design Automation and the Jasper Design Automation logo are trademarks or registered trademarks of Jasper Design Automation, Inc. All other trademarks mentioned are the property of their respective companies.

companyNews - 18 February, 2010 - Jasper: EASii IC Working With Jasper To Promote Formal Innovations In Europe

2010-03-10 10:58:20

MOUNTAIN VIEW, Calif. – Feb. 18, 2010 – Jasper Design Automation, provider of advanced formal technology solutions, today announced it is working with France’s EASii IC, a well-known European electronic-design consulting company, to accelerate the adoption of formal verification methods and increase understanding of how they apply across the entire spectrum of chip design, from architecture to signoff, with its customers. “At EASii IC we are proud to collaborate with the leading supplier of formal verification,” said Francois Cerisier, IC Verification Expert, EASii IC. “We believe our combined efforts to provide expert services using Jasper tools will be a real advantage to our customers in order to get their projects right the first time, and on time.” “We look forward to opening new markets and applications for formal with EASii IC, and with the combined power of Jasper technology and EASii IC consulting solving a broad spectrum of design challenges,” said Jasper Vice President of Marketing, Holly Stump. About JasperLinks EASii IC becomes the newest member of JasperLinks which creates comprehensive solutions integrating Jasper formal verification with other EDA solutions and services in the SoC flow. JasperLinks is open to companies in the design ecosystem including IP vendors, design services firms and consultants, and EDA partners. Interested parties may contact Jasper for more information about the program at info@jasper-da.com About Jasper Design Automation Jasper delivers industry-leading EDA software solutions for semiconductor design, verification, and reuse, based on the state-of-the-art formal technology. Customers include worldwide leaders in wireless, consumer, computing, and networking electronics, with over 150 successful chip deployments. Jasper, headquartered in Mountain View, California, is privately held, with offices and distributors in North America, South America, Europe, and Asia. Visit www.jasper-da.com to reduce risks; increase design, verification and reuse productivity; and accelerate time to market. Jasper Design Automation, JasperLinks and the Jasper Design Automation logo are trademarks or registered trademarks of Jasper Design Automation, Inc. All other trademarks mentioned are the property of their respective companies.

companyNews - 18 February, 2010 - BoneSupport: BONESUPPORT hires Fredrik Groth as Chief Financial Officer

2010-03-10 10:43:52

BONESUPPORT, a Swedish medical technology company that develops injectable bone filler, has hired Fredrik Groth as its new Chief Financial Officer. With more than 20 years of experience in the Swedish industrial sector, Mr. Groth was last employed by Cardo AB, where he served as Senior Vice President and head of the Pump division, as well as other senior positions. Mr. Groth will strengthen BONESUPPORT’s organization in general and its financial team in particular. Fredrik Werner, the former Chief Financial Officer, will remain on the team and manage new projects designed to prepare the company for the accelerated growth that is projected over the next few years. 'We are in a highly expansive sector,' says BONESUPPORT President Fredrik Lindberg. 'That requires a more dynamic financial team, and Mr. Groth has just the strategic expertise we were looking for. He also represents a key asset in our ongoing planning and commercial development effort.' In addition to Cardo, Mr. Groth has long experience at such listed companies as Trelleborg AB and Svedala Industri AB – as well as the Sixth Swedish National Pension Fund – as Division head, CFO and other senior positions. 'BONESUPPORT faces a number of exciting challenges,' says Mr. Groth. 'After many years at big companies, I'm looking forward to participating in a smaller, fast-growing entrepreneurial organization. I hope and believe that my knowledge and experience can help take BONESUPPORT to the next step in its development.' Mr. Groth took over as Chief Financial Officer of BoneSupport on February 1, 2010. For additional information, feel free to call: Fredrik Lindberg, President +46 708 86 53 70 Fredrik Groth, Chief Financial Officer +46 735 15 53 24 Press photos are available at www.bonesupport.com

companyNews - 16 February, 2010 - Xtract: Xtract powers next evolution in mobile social intelligence with upgrade to Social Links

2010-03-10 10:08:50

FINLAND, 16 February, 2010 – Xtract, the leading provider of social intelligence-based analytics solutions, announced today an upgrade to its flagship social intelligence platform, Social Links. Social Links enables network operators to analyse the behaviours and interactions of mobile subscribers within the network, helping them to monitor and identify the best targets for revenue generating targeted messaging campaigns. Key benefits of the new platform include product launch capabilities for totally new kinds of products, increased personalisation features and new dashboard reporting functionality, allowing operators to effectively monitor churn virality across the mobile network. Social Links is already helping operators worldwide and in one recent case gave the selected operator a percentage product take-up almost 4 times that of the competition. Mobile subscribers increasingly seek to engage with more applications and enriched services. Industry analysts predict the app download market to generate revenue of up to $4.2 billion by 2013[1] and research predicts that mobile application store users will quadruple to more than 100 million in five years[2]. This presents a major revenue-generation opportunity for operators. On the other hand, churn continues to be a major threat, especially in volatile prepaid markets. Randomly or poorly targeted marketing will result in a lost opportunity in both cases. Xtract has seen several examples in prepaid markets, where incentivising subscribers, who were not going to churn, with campaign offers actually destroys secured revenue. Another recent phenomenon has been to launch new services to subscribers with SNA, but relying only on non-contextual influencers to drive the launch virally – leading to failure. Xtract believes that successful targeting relies on the operator’s ability to analyse a combination of a mobile subscribers’ propensity to do something, combined with their influence within the fabric of the network. The analysis of mobile subscribers’ social context aware propensity to do something, combined with their influence has proven itself in Xtract’s Social Links platform. It allows operators to effectively harness key influencing factors of customer pull and target even subscriber groups that have traditionally been more challenging to reach, particularly the pre-paid market which makes up 77% of global subscriber share. Social Links also allows operators to benefit from the value of demographic prediction capabilities in targeting pre-paid subscribers, as well as the power of predictive social network analytics (SNA) in churn prevention, new product launches and the top-up marketing required for operators to retain a loyal pre-paid subscriber base. “Over the past twelve months, we have witnessed a shift in industry perception in the value of social network analytics, as the idea has evolved from initial hype and buzz of conception through to a mature, valuable network asset. As a result, many operators are beginning to recognise the business benefits of analytics as a solution to unlocking the gates to previously untapped revenue y,” said Mika Lindholm, CEO, Xtract. “As leader in this continually developing space, Xtract is ideally placed to forge the way in driving increased awareness of its value and benefits. Our platform allows us to build further on the success of our pioneering technology, enabling mobile operators to expose and harness the value of subscriber network interactions and drive valuable revenue opportunities through a combination of greater understanding, sophisticated product marketing and targeted, personalised campaigns.” The key benefits of Social Links 3.5 include:

Product launch capability: Operators are able to use analytics for the launch of more targeted, novel kinds of products
Tagging targets: The predictive analytics of Social Links produces a scoring list for campaign targeting. Social Links analyses subscribers in the target list, and targets with specific features can be tagged to further personalise messages, media and offers for smaller subgroups. New dashboard reporting on churn virality in the operator’s network.

1) Yankee Group, ‘Forecasting The U.S. Mobile App Gold Rush’, www.yankeegroup.com 2) In Stat, ‘The Apps Store is Born: Smartphones Enable New Marketing and Advertising Opportunities Worldwide’, www.instat.com About Xtract and Social Links Xtract is the leading provider of Social Intelligence based analytic solutions and services to mobile operators. Its tools analyse the wealth of customer profile and service usage data to predict the propensity of subscribers and those in their social network to either churn or increase spend, and influence others to do likewise. Consumer behavior is analysed on a far deeper level than by using historical data alone, also gaining insight into and understanding how customers communicate with each other, and who are the most influential in the network. Xtract also provides custom analytics to other verticals especially in the Finnish market. The core offering is dynamic segmentation based on rich data feeds, with other applications include optimization and fraud detection. Xtract Contact: Sari Aapola Sari.Aapola@xtract.com PR Agency Contacts: Chrissie McGoldrick cmcgoldrick@miliberty.com +44 207 751 4444 Elena Dunn edunn@miliberty.com +44 207 751 4444

companyNews - 15 February, 2010 - Ignis: Ignis signs first major supply agreement for Optical Splitters in North America.

2010-03-10 09:55:39

North America is now accelerating deployment of high speed fiber networks to meet the ever increasing demand for broadband services. Growth in FTTp projects are being further aided by federal funds which are beginning to flow from the US broadband stimulus program. ”We are proud to team our optical fabrication and technology with the superior optical component packaging of one of the most innovative fiber management supplier in North America,” commented Matt Lee, Chief Operating Officer of Ignis ASA. ”As the leading provider of optical component products to the largest FTTH deployments in the world, Ignis is pleased to bring our standards of quality and delivery to Clearfield and build a long and mutually rewarding relationship,” said Mr. Lee. “Clearfield has designed an optical component package that has been field-proven in the harshest of environments. Thousands have been deployed and have weathered the extremes of Alaska winters to Alabama summers,” explained Johnny Hill, Chief Operating Officer of Clearfield. ”Our partnership with Ignis cements our ability to provide an increasing volume of highly reliable, quality products,” said Mr. Hill. Ignis does most of its business today in Asia and has a strong presence there with its current product portfolio. However, the company is aggressively marketing its products globally. For Ignis, the agreement with Clearfield marks a break-through achievement in the North American market and is a milestone in the Ignis growth story. About Ignis Ignis ASA is comprised of three subsidiaries including 69.3% ownership in Ignis Fira in Korea, the wholly owned Ignis Photonyx in Denmark and Ignis Syntune in Sweden. Ignis is a leading international provider of optical splitters, multiplexers, and state-of-the-art widely tunable lasers for applications ranging from fiber-optic communications to sensor systems. Headquartered in Oslo Norway, Ignis ASA is listed on the Oslo Stock Exchange (OSE: IGNIS). About Clearfield Clearfield, Inc. designs and manufactures the WaveSmart Platform of Powered Optical Signal products, including the WaveSmart PowerNode 1550 EDFA, and the FieldSmart Fiber Management Platform, which includes its latest generation FieldSmart Fiber Distribution System (FxDS), FieldSmart Fiber Scalability Center (FSC) and FieldSmart Fiber Delivery Point (FDP) series. The FxDS, FSC and FDP product lines are build upon the Clearview Cassette, delivering the industry’s only fiber management platform that is built upon a single architecture. Scaling from 12 to 1728 ports, FieldSmart supports a wide range of panel and cabinet configurations, densities, connectors and adapter options, and are offered alongside an assortment of passive optical components. Clearfield provides a complete line of fiber and copper assemblies for inside plant, outside plant and access networks. Clearfield is a public company, traded on NASDAQ: CLFD. For further information, please contact: Thomas Ramm, Chief Executive Officer, Ignis ASA +47 913 70 795 thomas.ramm@ignis.com Walker Kinman, Chief Financial Officer, Ignis ASA +46 70 722 6513 walker.kinman@ignis.com

companyNews - 15 February, 2010 - Aepona: Aepona Chosen by GSMA for OneAPI Commercial Pilot

2010-03-10 09:50:19

Mobile World Congress, Barcelona, 15th February 2010 - Aepona, a global provider of telecoms software products and services headquartered in Belfast, Northern Ireland, today announced that it has been selected by the GSMA for its launch of the world’s first commercial implementation of OneAPI, a groundbreaking initiative that aims to make it much easier for application providers and enterprises to mobile-enable their applications and services across multiple operators. The service is being launched in Canada as a commercial Pilot, connecting to the three major Canadian mobile operators – Bell Mobility, TELUS and Rogers Wireless. The GSMA chose Aepona as its prime contractor and platform supplier for the Pilot following a rigorous selection process. Aepona is providing its Universal Service Platform (USP) together with managed services, including application provider on-boarding, developer support and platform management. In delivering the Pilot platform, Aepona is working with Transaction Network Services (TNS), who is providing the hosting infrastructure and operational services and expertise required to implement a carrier-grade, highly available commercial system. Graham Trickey, Senior Director at the GSMA responsible for the OneAPI initiative commented: “We have been working with Aepona since the beginning of the OneAPI project in 2008, initially to implement the OneAPI Reference Implementation which was successfully launched at Mobile World Congress in 2009. Since that time, we’ve made significant progress in developing a commercial framework for OneAPI, and I’m delighted that we are now in a position to launch a real commercial OneAPI service - an achievement that has been helped by the expertise and dedication of the Aepona team. Aepona was chosen because its platform combines the essential business and technical functions for an aggregated commercial API service into an integrated solution.” Aepona's CEO, Al Snyder, said: "We are delighted to have been selected by the GSMA on this pioneering project. The OneAPI Commercial Pilot in Canada demonstrates Network as a Service and Mobile Cloud Computing in action, where OneAPI-based Telco resources can be accessed on-demand via the Cloud and mashed-up with Web and Device APIs to create or enhance almost any web, device, enterprise or desktop application. This initiative will benefit the entire mobile and web applications community, from consumers, developers and enterprises through to mobile operators and aggregators. We commend the GSMA's leadership in helping to drive the Mobile Cloud Computing vision towards commercial reality." About Aepona Aepona provides products and services to Telcos globally, enabling them to adopt the emerging Network as a Service (NaaS) business model and unleash the full power of their network assets. With NaaS, Telcos can profit from the current trend towards Mobile Cloud Computing by publishing and monetizing their assets as Web-based APIs towards Enterprises, Web-Based Service Providers and Application Developers. Aepona's products are used by operators globally to power 1.2 billion monthly transactions and deliver $1 billion annual revenues to operators, application and content providers. Aepona is also the technology provider for the GSMA's OneAPI initiative For further information contact: Michael Crossey Vice President Marketing, Aepona michael.crossey@aepona.com +44 7734 318210 www.aepona.com

companyNews - 12 February, 2010 - Isconova: Great expectations—Isconova to receive the 2010 Bona Postulata Prize

2010-03-09 17:21:49

Isconova has been awarded the 2010 Bona Postulata Prize, for being a growing company with a great potential to become even more successful. The Bona Postulata Prize [1] is not intended to be a reward for what the company has accomplished so far — it is awarded based on the company’s imminent opportunities and existing potential. The founders are 15 well known companies and organizations with the purpose to help local companies getting attention, support and media exposure. Bona postulata is Latin for great expectations. Lena Söderström, CEO of Isconova commented: “The prize is an appreciated recognition and an inspiration to us in our efforts to establish Isconova as a leading provider of vaccine adjuvants” About Isconova AB Isconova AB develops, manufactures, out-licenses and sells state-of-the art adjuvants for the creation of highly effective antigen delivery systems for vaccine development, antibody production and immune response studies. In addition, the company sells reagents for formulating custom made complexes for the end-user. The products are based on the proprietary ISCOM technology platform and the market is global. Isconova was founded in 2000 as a spin-off from the Swedish University of Agricultural Science in Uppsala to further develop the ISCOM technology and make it commercially available and accessible. For more information, visit Isconova’s website: www.isconova.se Isconova AB, Uppsala, Sweden Lena Söderström, CEO Phone: +46 18 57 24 00 E-mail: lena.soderstrom@isconova.se [1] www.bonapostulata.se

companyNews - 10 February, 2010 - Heptagon: Heptagon Shipping 100 Millionth CMOS Imager Lens

2010-03-09 17:17:15

“Heptagon has a truly unique and proven value proposition: Optics which are glass-like in quality, being lead-free reflow and Telcordia compatible, but manufactured in the same wafer-scale format as the CMOS image sensor, LED and VCSEL technologies we support. This technology allows us to quickly ramp from several millions to several tens of millions of components per month and enables our customers to benefit from wafer-scale integration of optics with semiconductors,” says Chuck Milligan, Heptagon’s CEO. “The benefits of our technology have driven the demand for these first 100 million units, and the scalability of the technology has enabled us to meet this demand.” “The lens solutions we are shipping have progressed from simple, but extremely tiny, singlet lenses to stacks of lenses enabling high-quality VGA and Megapixel resolutions,” Chuck continues. “Shipping 100 million lenses is a significant milestone for Heptagon, and we believe it places us well ahead of any of our followers in wafer-scale lens technology. With strong continuing demand for current products, and a number of new products ranging from VGA to 8+ megapixel in the pipeline, we expect to be announcing over two hundred million of lenses shipped within the next few quarters and to continue growing from there. We continue to enable and progress a strong shift in the mobile CMOS Imaging market to reflowable wafer-level optics and wafer-level camera assembly, providing our customers with a competitive advantage in the miniaturization and cost-reduction of CMOS Imagers and enabling exciting new applications for these high-performance mini-cameras.” About Heptagon Heptagon designs and manufactures advanced micro-optics products for OEM suppliers. Heptagon's components are used in many applications including CMOS imaging, LED optics, display, optical communications, consumer electronics and industrial optics. Heptagon is headquartered near Zurich, Switzerland and has its volume manufacturing facility in Singapore. For further information please contact: Heptagon Chuck Milligan, CEO, +41 (79) 349 1791 chuck.milligan@heptagon.fi

companyNews - 8 February, 2010 - Ignis: Ignis signs new splitter agreement in China

2010-03-09 17:12:32

The first purchase order of approximately USD 1.3 million for delivery H1 2010 has been placed upon signing of the agreement. Ignis continues to experience substantial demand for splitter products in Asia and keeps growing their business in the Asian markets. Many Asian telecom operators are ramping up their expansion of high speed broadband networks, and splitter products play an important role in these networks. - Asian telecom operators are investing aggressively in fiber networks and the demand for Ignis products is noticeably increasing. However, the market activities are not limited to Asia as increasingly more inquiries and purchase orders are coming from EU and USA, says Matt Lee, COO in Ignis ASA. Ignis is developing a strong customer base around the world and China represents a strategically important market to the company. This announcement marks the third new agreement entered into this year in China demonstrating Ignis’ ability to compete effectively in this market. About Ignis Ignis ASA is comprised of three subsidiaries including 69.3% ownership in Ignis Fira in Korea, the wholly owned Ignis Photonyx in Denmark and Ignis Syntune in Sweden. Ignis is a leading international provider of optical splitters, multiplexers, and state-of-the-art widely tunable lasers for applications ranging from fiber-optic communications to sensor systems. Headquartered in Oslo Norway, Ignis ASA is listed on the Oslo Stock Exchange (OSE: IGNIS). For further information, please contact: Thomas Ramm, Chief Executive Officer, Ignis ASA Tel: +47 913 70 795 Mail: thomas.ramm@ignis.com Walker Kinman, Chief Financial Officer, Ignis ASA Tel: +46 70 722 6513 Mail: walker.kinman@ignis.com

companyNews - 8 February, 2010 - Apptus: Leading Directory and Search Service Provider Fonecta boost search hit rate with Apptus

2010-03-09 16:33:47

“Apptus Taxonomy Enrichment was the only tool that worked according to our needs. For example, it's the only tool that has a fully functional keyword suggestion feature, which was on of our most important requirements. And Apptus' project management and support was the best of all our pilots.” says Saara Hyvönen, Service Development Manager at Fonecta. Increasing the number of relevant keywords makes it easier for Fonecta's users to find exactly the company they are looking for. This will in turn make it easier to find specialized niche companies and thereby improve the hit rate. And with more relevant keywords, Fonecta's site will also get better exposure when users search on external search engines. “Apptus Taxonomy Enrichment tool analyses the content of Fonecta's customers’ web pages and suggests a number of relevant keywords related to each category. By detecting keywords and making them searchable, it dramatically reduces the frequency of no hits.” says Michael Mokhberi, CEO at Apptus. After the implementation Fonecta's database has five times as many keywords and ten times as many brands as before. “The Apptus Taxonomy Enrichment tool manages all keywords in one single automated process which makes it significantly faster than if done manually. This makes it possible for us to update the entire taxonomy on a quarterly basis at av very low cost.” says Saara Hyvönen. For more information, please contact: Michael Mokhberi, CEO at Apptus Mobile: +46 701664102 E-mail: michael.mokhberi@apptus.com Apptus idea is to bring buyers and sellers closer to each other by providing instant access to relevant information. Since year 2000 the company has developed solutions based on the platform Theca, which optimizes the synergies between search, content and sales. Apptus is a private company, headquartered in Sweden with sales organizations in Europe and North America. Among the customers are leading companies within e-commerce and online directories in 18 countries, for example Yell.com, ATEA, CDON, De Gule Sider, Eniro, Fonecta, Hitta, Lokaldelen, Panduro Hobby, Quebecor, Truvo and Bokus . For more information, please visit www.apptus.com Fonecta is the fastest growing media company in Finland and the market leader in directory services. 110,000 businesses are using Fonecta’s sales enhancement solutions and its comprehensive services are being addressed for information search more than 2 million times every day. Fonecta employs over 1,000 persons around Finland. In 2009, the Group’s net sales amounted to Euro 187 million.

companyNews - 5 February, 2010 - InnovationsKaptial: Wind River to Add Virtutech Simics Products to Comprehensive Embedded Software Portfolio

2010-03-09 16:02:45

Wind River will sell and support Virtutech’s flagship development platform, Simics, as a stand-alone product and will continue to support all current architectures including ARM, Intel, MIPS and PowerPC. Simics will allow Wind River to offer a market-leading virtual systems development solution in a growing market segment of virtualization and simulation tools for device software development. “The addition of Virtutech’s development platforms to our product line will allow Wind River to offer greater value to customers across the entire product lifecycle and deepen current relationships with our broad set of silicon partners,” said Ken Klein, president, Wind River. “Time-to-market remains the single most challenging issue that sophisticated electronic equipment manufacturers need to address and ultimately control in order to remain competitive. With the addition of the Simics products, Wind River adds a key solution to further help customers improve time-to-market, as system complexity and ever more stringent demands upon overall system quality rapidly increase.” “Through our long-standing partnership with Wind River, it became evident that both companies shared a vision of how we can help the electronic systems market rethink how it goes about complex product development by deploying virtual platforms,” said John Lambert, CEO, Virtutech. “Time and again, Virtutech has helped customers and partners improve time-to-market by enabling the full sweep of systems development activities to take place on a virtual platform, freeing them up to apply new and innovative ways of running systems development projects. By combining with Wind River, we now have the opportunity to dramatically accelerate the spread of this key market trend and to bring the benefits of virtual platforms to a broader audience.” Simics provides binary-compatible hardware simulations that operate completely within a virtualized environment running on standard laptop or desktop PCs. This strategy allows OEMs to undertake critical software development activities on a virtual platform, independently of any hardware development schedules, semiconductor availability constraints or other limitations. This also allows semiconductor manufacturers to redefine complex system-on-chip development with greater ecosystem support and customer engagement. Virtutech therefore enables customers to manage complexity, drive improved quality and achieve higher productivity, all while lowering capital expenditure and shortening total development time. Acquired by Intel last year, Wind River develops operating systems, middleware (software found between an OS and software application), and software design tools for a variety of embedded computing systems. Its main products include VxWorks, the market-leading proprietary and multicore-ready real-time operating system, and commercial-grade Linux software platforms. The company also provides design services and software expertise, including custom-built solutions, development tools and device testing products. With thousands of customers, Wind River technology is relied upon by most major computer and networking communications companies, and is used by corporations and government agencies such as Alcatel-Lucent, BMW, Boeing, Bombardier Transportation, Mitsubishi, Motorola, NASA, Sony, Verizon and many more. Intel’s acquisition of privately-held Virtutech is expected to be completed this quarter. Terms of the deal are not being disclosed. About Virtutech Virtutech, Inc. is the leader in product development process improvement through virtualized systems development (VSD). Virtutech Simics® allows for a revolutionary change in the product development process at a full system level rather than a component level and is a commercial solution that uniquely delivers the four most important criteria for successful deployment of hardware virtualization in the electronics equipment development process: speed, scalability, model availability, and control. Simics customers report reduced time to market, better project risk management, lower capital expenditure, product development cost and maintenance as well as increased quality and individual productivity. Virtutech serves the needs of the world’s leading OEMs in the high-performance computing, aerospace and defense, telecommunications, networking and semiconductor industries. Customers include Cisco, Ericsson, Freescale Semiconductor, GE Avionics, Honeywell, IBM, Lockheed Martin, Nortel and Northrop Grumman. Virtutech is an active participant in organizations to drive adoption of VSD such as ARM Connected Community, Eclipse.org, IBM PartnerWorld, Multicore Association, Power.org, OSCI and Spirit Consortium. For more information, visit www.virtutech.com About Wind River Wind River, a wholly owned subsidiary of Intel Corporation (NASDAQ: INTC), is a world leader in embedded and mobile software. Wind River has been pioneering computing inside embedded devices since 1981 and its technology is found in more than 500 million products. Wind River is headquartered in Alameda, Calif. with offices in more than 15 countries. To learn more, visit Wind River at www.windriver.com or blogs.windriver.com CONTACTS Bryan Thomas Wind River Tel: +1 510-749-2414 bryan.thomas@windriver.com

companyNews - 1 February, 2010 - Martin Dawes: Martin Dawes Systems Shortlisted for Total Telecom World Vendor Award

2010-03-09 16:00:07

The World Vendor Awards are the only independent impartial awards that are focused on telecom vendors. They recognize excellence amongst the companies supplying hardware, software and services for the global telecommunications industry. The World Vendor Award winners will be announced on 5th May 2010 in London. The Managed Services portfolio from Martin Dawes Systems provides an integrated, hosted solution for end-to-end customer experience management, carefully tailored to balance flexibility with cost-effective operation. It offers a consolidated system for total convergence support: Commercial convergence for multiple products on one bill. Product convergence for bundled offerings such as fixed- mobile convergence, triple play and quad play. Billing convergence for prepaid and postpaid services on the same system, enabling hybrid services for enhanced ARPU opportunities. Network convergence that accommodates multiple standards for the next generation of telecoms, including mobile, fixed, broadband, SIP, Wi-Fi and VoIP Dewi Thomas, Managing Director, Martin Dawes Systems said: “Our Managed Services solution exemplifies how we take responsibility, helping our customers move forward with innovative customer care and operational excellence. Selection for the WVA shortlist is a great independent endorsement of how successfully we are supporting some of the industry’s leading players.” BT Retail, Talk Talk (AOL Broadband) and Aircell are among the major CSPs that depend on Martin Dawes Systems’ Managed Services to run their customer support systems. The service is being used to support Aircell’s Gogo inflight mobile broadband service and resolve customer support issues in US commercial airliners travelling 600 miles per hour and at 10,000 feet. Martin Dawes Systems’ Managed Services has already won a World Billing award in 2006 for its deployment at BT Retail. In the Best Support System category of the World Vendor Awards, Martin Dawes Systems is competing against Aito Technologies, Comptel Corporation, and Sigma Systems. For more information please visit www.martindawessystems.com

companyNews - 1 February, 2010 - Hymite: Hymite will sell portfolio of wafer-level semiconductor packaging patents

2010-03-09 15:53:22

The assets disclose cost-efficient wafer-level semiconductor packaging techniques applicable to high-power and high-frequency applications, including LED, MEMS, and optical communications component packaging. Key technologies of this portfolio include high-current-carrying through-wafer interconnects (through-silicon via — TSV), which enable wafer-level surface mount (SMT) chip-size packaging (WLPCSP). WLPCSP can improve manufacturability by reducing costs, increase performance, enable reduced component size, and improve product scalability. The patents also include a high-power/brightness LED packaging solution that offers excellent thermal performance in a highly manufacturable platform and MEMS packaging technology that features flux-less hermetic sealing on the wafer level with controlled internal package atmosphere. Several of the technologies included in this portfolio have been developed to the production phase and the related know-how is included. “Hymite is pleased with the general acceptance of its unique technology in the market - major players in high speed communications, high-power LEDs and MEMS have already engaged Hymite on developing unique products,” stated Christian Tang-Jespersen, Hymite president and CEO. To learn more about the patents available for sale in this portfolio, contact ICAP Ocean Tomo at (866) 779-8363 or at patent.brokerage@us.icap.com ICAP Ocean Tomo is the intellectual property brokerage division of ICAP, an interdealer broker and provider of post trade services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, foreign exchange, emerging markets, equities and equity derivatives through voice and electronic networks. ICAP is also the source of global market information and research for professionals in the international financial markets. For more information, visit www.icap.com

innkapNews - 5 February, 2010 - InnovationsKaptial: Wind River to Add Virtutech Simics Products to Comprehensive Embedded Software Portfolio

2010-02-26 10:23:16

companyNews - 21 January, 2010 - Silecs: Silecs becoming an international frontrunner

2010-01-29 14:43:57

“Business cycles have actually helped our company to grow. Our operating model is based on speed, flexibility and cost-effectiveness. Our patented technology enables our customers to boost their production and enhance the performance of their end products,” says Silecs’s CEO Kok-Whee Teo. In Teo’s view, the whole sector has a bright future because the global market for chemicals and materials needed by the electronics industry is forecast to reach the EUR 20 billion mark next year. “Silecs has good prospects for becoming an international frontrunner as we systematically pursue our targeted business strategy. Our goal is to reach annual turnover of MEUR 200 by the end of 2015,” promises Teo. Silecs’s technology enhances the performance, picture quality, colour shading and service life of flat-panel TVs, digital cameras, solar cells, LED applications, and memory cards for consumer electronics. The technology reduces power consumption and simplifies the manufacture of microcircuits, which cuts production costs and retail prices of end products. RAPID ADAPTABILITY GIVES COMPETIVE EDGE “Our competitive edge derives from solutions tailored for the customers, which are implemented cost-effectively, flexibly and ecologically,” says Teo. Silecs currently employs 35 people. The company’s R&D and plant are located in Espoo, Finland, while management and sales are concentrated in Singapore, Hong Kong and Taiwan, close to the main markets. The company also has extensive cooperation in Japan as well as sales agents in Europe and the USA. Silecs’s effective networking model allows the company to serve its customers around the world. “Although competition in the microelectronics industry is very intense, this year we’ve won a number of new contracts,” says Teo. The competition includes major global players, but Teo believes in his company’s carefully crafted operating model. “We are where our markets are. Through our network we can adapt quickly to our customers’ requirements.” CREATIVITY AND EFFICIENCY SUPPLEMENT EACH OTHER Kok-Whee Teo, who was appointed CEO of Silecs just over a year ago, has a long career in the international electronics industry behind him in, for example, Texas Instruments and Molex. He says he brought solid management and sales expertise to Silecs. “I was interested in taking over the helm of the company because it offers its customers good technology, solutions and production.” Singapore-born Teo describes his job of managing a Finnish company as inspiring and satisfying. Teo has found it easy to assimilate Finnish ways of working, and communication with Finns has been straightforward. “I’ve worked in different countries in numerous international companies, and also with Finns, during my career. From experience I can say that experts from different countries blend into the company’s own work culture fairly easily, despite national differences. A good manager can infuse his or her team with the company spirit and get people involved. Silecs’s employees are motivated to work both as a team and as individuals.” Silecs’s model combines the best features of both Finnish and Asian working cultures. “Finns are very creative and committed to their work. Asians, for their part, are very systematic, but not necessarily creative enough in development tasks.” SALES AND MARKETING ARE THE SHOWCASE Established in Espoo, Finland, in 2001, Silecs’s roots go back to research work conducted by the Technical Research Centre of Finland VTT that focused on reducing the size of microcircuits and improving the quality of end products by means of new materials. The company’s product and technology solutions now have over 30 patents or patents pending worldwide. The company was awarded the InnoFinland Prize of the President of the Republic in 2006. In 2008 Silecs received a MEUR 6 investment from Swedish InnovationsKapital, British Tempo Capital Partners and Finnish Industry Investment. Kok-Whee Teo believes that the involvement of private equity investors gives much more muscle to strengthening the company’s sales and marketing. “A technology company’s biggest challenge is to sell its expertise to customers in an attractive way. Alongside engineering excellence, a successful company needs just as much excellence in marketing and the ability to understand the needs of the global operating environment,” says Teo. www.silecs.com

companyNews - 21 January, 2010 - Projectplace: New social functions in Projectplace for iPhone

2010-01-29 11:19:15

The main addition is the new social functions, aiming to increase team collaboration in projects. Every user has a personal guestbook/wall where project members can add comments. Via a chat you can also send private messages to team members. Another social feature is the "chatter" where you can write messages and listen in on your project colleagues, a project wall for the project team. The application will notify you with a ping for project events, when something is assigned to you, when someone writes in your guestbook or sends you a message. You can also follow a document to get notifications about changes or comments. All notifications are shown in a list with a history of older actions. - We have two main goals with this release, says Peter Strömberg, Manager of Projectplace Labs. Firstly its an experiment trying to find out how social interaction should be supported on a phone. Secondly we wanted to leverage the experience from the previous version of the application to help people on the go to manage their project commitments even better. The application also allows you to answer meeting requests on the run, update issue statues as well as read and review documents. Through the contact list its easy to keep in contact with colleagues by writing on their walls, sending them a private message, giving them a call, sending them an SMS or an e-mail. Projectplace for iPhone (Beta) is completely free for all Projectplace users and is released in English only. The application is available for users on all of Projectplace markets. Being a beta, some features might be modified or taken away throughout further development. User feedback will continue to guide the future development of the application. For more information please visit: www.projectplace.com Media contact: Anna Ålenius Mathson, International PR Manager Phone: +46708930246, email: anna.alenius.mathson@projectplace.com Since 1998, Projectplace International has developed and provided Europe's leading web tool for project collaboration. The company, with 100 employees and 500 000 users is based in Stockholm, Sweden, with local offices in Denmark, Germany, The Netherlands, and Norway. For more information, please visit www.projectplace.com

companyNews - 20 January, 2010 - Aepona: Aepona Shortlisted in the 2010 GSM Association Global Mobile Awards

2010-01-29 11:12:15

Belfast, 20th January 2010 - Aepona, a global provider of telecoms software products and services headquartered in Belfast, Northern Ireland, today announced that its Universal Service Platform (USP) has been shortlisted within the Best Service Delivery Platform category in the GSMA Global Mobile Awards 2010. “This is a highly prestigious award and we are delighted to be shortlisted”, said Michael Crossey, Aepona’s Vice President of Marketing. “The Universal Service Platform enables Telcos to evolve their business towards what we term the “Network as a Service” (NaaS) model. In the same way that Apple has opened its iPhone platform to developers, resulting in thousands of new services for consumers, the USP enables telecoms operators to open their networks in a controlled, secure manner, using Web Services APIs based on the GSMA OneAPI specifications.” Aepona’s Universal Service Platform incorporates a powerful Payments and Settlement Engine (PSE) that allows both operators to monetize access to their networks, and Application Providers to monetize their services by charging end users via their mobile bill. By providing both OneAPI-compliant access and monetization on a single platform, USP makes Network APIs much more attractive to developers and Enterprises than before, resulting in many more value-added services for enterprises and consumers. During February’s Mobile World Congress in Barcelona, Aepona CEO Al Snyder will be speaking on the conference session Mobile Applications - Innovation Vs Fragmentation, discussing the topic “How to Make Revenue from Network APIs”. “Our congratulations to all nominees for the Global Mobile Awards 2010,” said Rob Conway, CEO and Member of the Board of the GSMA. “Competition for these awards is fierce, with more than 500 entries - including many of an exceptional standard - and a highly discerning independent judging panel to impress; to be shortlisted is quite an achievement. We look forward to the unveiling of the winners at the Mobile World Congress in Barcelona next month.” About Aepona Aepona provides products and services to Telcos globally, enabling them to adopt the emerging Network as a Service (NaaS) business model and unleash the full power of their network assets. With NaaS, Telcos can profit from the current trend towards Mobile Cloud Computing by publishing and monetizing their assets as Web-based APIs towards Enterprises, Web-Based Service Providers and Application Developers. Aepona's products are used by operators globally to power 1.2 billion monthly transactions and deliver $1 billion annual revenues to operators, application and content providers. Aepona is also the technology provider for the GSMA's OneAPI initiative For further information contact: Michael Crossey Vice President Marketing, Aepona E: michael.crossey@aepona.com T: +44 7734 318210 www.aepona.com

companyNews - 19 January, 2010 - Ignis: Ignis awarded another splitter agreement in Asia

2010-01-29 11:03:32

Ignis is experiencing substantial growth of business demand in all product segments. Over the last year, Ignis has gained a particularly strong market position in Asia with a large portfolio of blue chip customers. - This is another proof of our competitive strength in the splitter chip segment. Together with our Asian customer we have formed a strategic partnership for increasing distribution of optical splitter modules in the fast growing Chinese market for broadband access, says Matt Lee, COO in Ignis ASA. China is showing impressing growth in online and broadband usage with more than 300 million Internet users where 90% have broadband access. China's broadband service providers, such as China Telecom, China Netcom and China Mobile, have deployed up to 15 million FTTx (Fiber-To-The-x) lines in 2009 and FTTx subscribers in China are expected to top 50 million in 2012. Ignis keeps investing significant time and efforts in the Asian broadband market to further improve its market position and win new blue chip customers in all parts of the region. About Ignis Ignis ASA is comprised of three subsidiaries including 69.3% ownership in Ignis Fira in Korea, the wholly owned Ignis Photonyx in Denmark and Ignis Syntune in Sweden. Ignis is a leading international provider of optical splitters, multiplexers, and state-of-the-art widely tunable lasers for applications ranging from fiber-optic communications to sensor systems. Headquartered in Oslo Norway, Ignis ASA is listed on the Oslo Stock Exchange (OSE: IGNIS). For further information, please contact: Thomas Ramm, Chief Executive Officer, Ignis ASA Tel: +47 913 70 795 Mail: thomas.ramm@ignis.com Walker Kinman, Chief Financial Officer, Ignis ASA Tel: +46 70 722 6513 Mail: walker.kinman@ignis.com www.ignis.com

companyNews - 18 January, 2010 - ActionPharma: ACTION PHARMA STRENGTHENS ITS EXECUTIVE MANAGEMENT BY APPOINTING A NEW CEO

2010-01-29 10:58:40

Action Pharma has strengthened its executive management by appointing Ingelise Saunders as a new CEO of Action Pharma. The appointment will bring substantial M&A and partnering expertise to the company. Søren Nielsen, previous CEO, continues as Chief Operational Officer (COO) in the executive management. “We are extremely pleased that we have recruited Ingelise Saunders as CEO of Action Pharma. Ingelise has a very strong executive management career in both the pharmaceutical and the biotech industry including Novo Nordisk A/S and Celltech Pharmaceuticals Ltd. (UK). Following the progress of the clinical development of its two lead programs, Action Pharma is now focusing on M&A and partnering, and Ingelise brings in a very strong track record in these areas” says Sten Verland, Chairman of the Board of Directors. Ingelise Saunders has more than 30 years of experience in the pharmaceutical and biotech industry. Previously, she was President and Chief Executive Officer of ACE BioSciences (DK) for five years. Prior to that, Ms. Saunders was the Chief Executive Officer for three years of Celltech Pharmaceuticals Ltd. (UK) with global commercial responsibility, and spent 16 years with Novo Nordisk in top level executive management positions, both in Denmark and in the UK. Ms. Saunders has a Cand. Pharm. degree from the University of Copenhagen, Royal Danish School of Pharmacy, and a Bachelor of Commerce degree in Marketing. She serves as a board member of Scandinavian Life Science Invest AB, Topotarget A/S, ALK-Abello A/S, Nordic Vaccine A/S (Chairman) and Evolva Holding SA. “With the two lead programs in clinical phase 1 and 2, there is significant partnering and M&A interest in Action Pharma. I am very excited to get involved at this crucial stage of Action Pharma’s development, and I look forward to working with the Action Pharma team and The Board of Directors to take the company to the next phase”, says Ingelise Saunders. AP214 is in phase II clinical development to prevent post-surgical kidney injury after major cardiac surgery. We have already obtained positive results in early phase I and IIa programs. AP214 is expected to reduce the inflammatory response as well as post-surgical reperfusion injuries, factors known to cause kidney injury and hence major increase in co-morbidity and mortality”, says Søren Nielsen, COO of Action Pharma. “AP1030 is under development for the treatment of type II diabetes associated with obesity. AP1030 has completed phase Ib clinical studies with potent effects on glucose metabolism. AP1030 is orally available (once daily), and combined with the potent effects, it has significant competitive advantages compared to current non-insulin antidiabetics”. The Action Pharma team has significant scientific expertise with more than 400 published scientific papers within these areas. Action Pharma is dedicated to the discovery, research and development of novel drugs targeting melanocortin receptors. In addition to prevention of kidney injury / organ failure, stimulation of melanocortin receptors has shown major promise as a novel treatment for type 2 diabetes, obesity and inflammatory diseases. The current pipeline of 4 compounds in development provides outstanding business development potentials. For further information, please contact: Sten Verland, Chairman of the Board Sunstone Capital A/S Lautrupsgade 7, 5 DK-2100 Copenhagen, Denmark verland@sunstonecapital.com Phone: +45 2012 6000 Ingelise Saunders, CEO Action Pharma A/S Dronninggaards Allé 136 DK-2840 Holte, Denmark ils@actionpharma Phone: +45 2020 3687 About Action Pharma A/S Action Pharma is a privately owned Danish biotech company. The main strategy of Action Pharma is to develop novel drug candidates targeting melanocortin receptors and bring these to clinical proof of concept for subsequent partnering. The drug candidates are first in class and exploit novel mode of action profiles with efficacy that is superior compared to the current market. Action Pharma has a pipeline of several patent protected drug candidates of which two are currently in clinical development and two in late preclinical development. Action Pharma is developing AP214 to prevent post-surgical kidney injury after major thoracic surgery. AP214 is currently being tested in a phase II clinical trial investigating the effect of AP214 on organ protection in patients undergoing cardiac surgery, who are at increased risk of kidney injury. Every year, more than 150,000 patients in the USA and EU undergo major thoracic surgery. Approximately 10-20% of these patients experience various degrees of kidney injury which again is associated with marked increase in mortality, co-morbidity and prolonged hospitalization. AP214 mediates its potent effect via the type 1 and type 3 melanocortin receptors. Initial results from an earlier phase II clinical trial in the US, and from a phase IB trial in human volunteers subjected to LPS-induced inflammation, revealed positive effects of AP214. AP1030, the lead compound within the company’s small molecule program, has potent pre-clinically documented anti-diabetic and anti-obesity effects. AP1030 is currently in clinical development in obese individuals in a two-week clinical trial with positive effects on glucose metabolism. AP1030 has the potential to be superior to other anti-diabetics including GLP-1 analogues, DPP-4 inhibitors and glitazones. Importantly, AP1030 can be administered orally (once daily) in contrast to GLP-1 analogues. The marked weight reducing effects observed in non-clinical pharmacodynamic models contrast the absence of weight reduction by other orally available antidiabetics (DPP-4 inhibitors and others). Thus, this makes AP1030 highly attractive in the market for type II diabetes associated with obesity. The mode of action of AP1030, first in class, involves a central melanocortin type 4 receptor mediated effect, thereby modulating appetite and central regulation of glucose metabolism plus a systemic anti-inflammatory melanocortin type 1 receptor mediated anti-diabetic effect aimed at reverting low grade inflammation in fatty tissue, and thereby reducing peripheral insulin resistance. In addition, Action Pharma develops AP1189 which is targeted for oral administration for the treatment of systemic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel diseases. Similarly, AP405 is developed for topical treatment of inflammatory skin diseases, such as atopic dermatitis. Action Pharma has a strong investor base of leading European investors, including Sunstone Capital, Global Life Science Ventures, InnovationsKapital, SLS Venture, Inventure Capital, and Oestjysk Innovation. For more information, please visit www.actionpharma.com

companyNews - 14 January, 2010 - Jasper: Jasper Advanced Formal Solutions at EDSF – Adding Value Throughout Design Flow Latest JasperGold®/JasperCore™ Release Coming to EDSF 2010 in Japan

2010-01-29 10:37:01

“These new features are highly valued by our customers,” said Dr. Claudionor Coelho, Jasper Vice President of Engineering. “Everything described here has been validated in extensive field trials with some of the world’s most advanced design teams, and greatly accelerates both the science and practical implementation of formal.” Powerful Proof, Exploration and Productivity Boosters The new release has been tested with leading IC design teams at major microprocessor, graphics processor, IP, and telecom/networking companies with outstanding results. A sampling of their comments: ”Easily handles unit-sized blocks, very impressive tool” ”Reads full cores and even multi-core designs” A new collaborative engine architecture automatically leverages information between engines to boost performance and obtain convergence on complex proofs. Other engines have increased JasperGold/JasperCore’s industry-leading capacity to handle even larger designs, and increase convergence on liveness properties. JasperGold now features a design explorer dialog where you can access a tree structure of the design logic starting from signals or properties. Design exploration facilitates greater understanding of the design structure and provides an interface to quickly construct the analysis region thus enabling a smooth transition to Jasper’s unique Design Tunneling™ feature for the proof of the most complex properties. Multi-cycle path analysis applies formal to the general static timing analysis (STA) issue. STA generates voluminous multi-cycle paths, and this JasperGold formal feature clearly identifies which of them will cause problems. JasperGold formal allows engineers to derive the benefits of X states without the associated risks. The use of unknown values (X states) can provide significant benefits in RTL verification, and can allow better logic optimization for synthesis. Sources of X include direct X-assignment and uninitialized logic. But uncontrolled or unexpected X propagation in simulation can also mask bugs, potentially leading to failures in silicon. Simulation alone cannot adequately simulate and observe all X states. The typical design methodology calls for appropriate control logic that prevents X propagation past "barrier" points. This flow detects Xs and displays a trace demonstrating the effect of their propagation on user-defined target signals. JasperGold detects functional errors not easily found in simulation, including incorrect clock-gating resulting in Xs for register values and incorrect control logic allowing Xs to propagate to output data buses for “valid” data. A new path sensitization analysis feature allows engineers to analyze the relationships between various signals, including cause and effect between their activities. In today’s complex designs, it is often difficult to understand how signals interact with each other; e.g., an input potentially affecting the value of the output. JasperGold now detects if a signal can actually affect the value of another signal in the design and displays such a trace if it can be found. Another JasperGold first is the addition of automatic memory abstraction in the Visualize™ flow, for even greater performance. Visualize automatically generates and manipulates waveforms without a testbench, answering “what-if” design questions and providing visual confirmation of design functionality which is especially useful for RTL development and debug. Jasper at EDSF 2010 These new products are being featured during EDSF 2010 at the CyberTec/Jasper Booth #304. For more information, or to register for a product demo, please e-mail for Targeted ROI: reducing risks; increasing design, verification and reuse productivity; and accelerating time to market. Jasper Design Automation and the Jasper Design Automation logo are trademarks or registered trademarks of Jasper Design Automation, Inc. JasperGold® is a registered trademark, and JasperCore™, Visualize™, Design Tunneling™ and ActiveDesign™ are trademarks of Jasper Design Automation, Inc. All other trademarks mentioned are the property of their respective companies.

companyNews - 18 December, 2009 - Jolife: New study; LUCAS CPR saves lives at cardiac arrest in the catheterization laboratory

2010-01-29 10:10:50

A group of patients that previously has been close to impossible to save, can now be saved with help of LUCAS mechanical chest compressions and continued coronary intervention. The catheterization laboratory of Lund University Hospital in Lund, Sweden, has since 2004 used the LUCAS Chest Compression System to sustain blood circulation in patients who have gone into a cardiac arrest during interventional treatment of myocardial infarction. The results which are published this week in the Journal of Resuscitation are very encouraging. During five years 11 patients out of 38 patients have been saved with a good outcome with the help of effective and consistent LUCAS chest compressions during a continued intervention. Dr. Henrik Wagner, one of the study authors, concludes that few, if any of these patients, would have survived without the use of LUCAS. “Rescuers who provide manual chest compressions interfere both with the X-ray equipment and the image. The attempts to reopen the coronary artery must be interrupted frequently while manual chest compressions are provided. The situation becomes very chaotic and stressful. It becomes a compromise between patient circulation and continued coronary intervention. In addition to this are rescuers, who provide manual CPR, exposed to high doses of X-ray”, says Dr. Henrik Wagner. “LUCAS interferes less and is mainly radiotranslucent. It allows us to visualize the coronary arteries in the most common X-ray projections. While LUCAS sustains circulation, the situation calms down considerably in the lab and we can focus on treating the cause of the arrest, which is often a total occlusion of a coronary artery”. The resuscitation time with continued intervention has been on average 30 minutes, but with a large variation of up to 90 minutes of CPR. The longest LUCAS treatment time of a survivor was 50 minutes. “This is the first full length article on a larger group of patients with cardiac arrests that occur during an intervention, and which are immediately treated with LUCAS CPR and continued PCI (percutaneous coronary intervention). It shows the value of having a LUCAS device stand by in every cath lab or hospital”, says Erik von Schenck, CEO of Jolife AB, which develops and manufactures the device. “In addition to this latest study, there are several more abstracts and presentations confirming the same life-saving benefits and usefulness of LUCAS in this setting, presented at congresses in Europe and US the latest years.” The study which is made on the pneumatic LUCAS 1 (model V1 and V2) is available electronically “in press” at the website of the journal of Resuscitation: www.resuscitationjournal.com Wagner et al: “Cardiac arrest in the catheterisation laboratory: A 5-year experience of using mechanical chest compressions to facilitate PCI during prolonged resuscitation efforts”. About LUCAS CPR LUCAS Chest Compression System is an easy-to-use and lightweight device that provides quality chest compressions according to the European Resuscitation Council and American Heart Association Guidelines for CPR (cardiopulmonary resuscitation). It assists rescuers in maintaining vital blood circulation in cardiac arrest patients. LUCAS is simple to use, applied within seconds and feasible for use in a majority of cardiac arrest patients. LUCAS is available in an electrically driven version (LUCAS 2) and a pneumatically driven (LUCAS 1). The mechanical CPR device has shown to increase operational efficacy and to improve the opportunities to save cardiac arrest patients. About Jolife AB Jolife AB, founded in 2000, develops and manufactures the LUCAS Chest Compression System. Jolife works closely with leading physicians and paramedics and is committed to research and development in order to continue to offer innovative products. The LUCAS Chest Compression Systems are sold in the major markets in the world. Based in Lund in southern Sweden, Jolife markets its products through an exclusive global distribution agreement with Physio-Control, Inc., a division of Medtronic Inc. – except in Sweden, Norway and Finland, where Jolife sells directly. Further information: Erik von Schenck, CEO, JOLIFE Tel: +46 46 286 5002 E-mail: evs@jolife.com Or Sara Lindroth, Marketing Director, JOLIFE Tel: +46 46 286 5024 E-mail: sara.lindroth@jolife.com Jolife AB Scheelevägen 17 223 70 Lund Sweden Tel: +46 46 286 5000 www.jolife.com www.lucas-cpr.com

companyNews - 15 December, 2009 - Martin Dawes: Leading Mobile Network Provider Receives Martin Dawes Analytics’ 2009 Customer Innovation Award

2010-01-29 09:57:30

Martin Dawes Analytics (MDA), a global process analytics software provider, announced that PLAY, the fastest growing mobile network operator in Poland, is the EMEA winner of its 2009 Customer Innovation Award. PLAY is using MDA’s Lavastorm Analytic software platform to dynamically analyze and respond to usage-based BI insight in near-real time. PLAY initially engaged MDA in 2007 to provide Revenue Assurance, Fraud Management, and Interconnect Billing, using MDA’s Lavastorm Analytic Software Platform. Lavastorm acquires and enriches voice and data event records, and enables both persistent and ad-hoc analytics for Fraud Management and Revenue Assurance, as well as interconnect traffic information and billing. Voice and data usage throughout PLAY’s network is acquired, enriched and stored within minutes of the transaction, and the company has received significant on-going financial value from the market-leading MDA data analytic platform. After the combined Revenue Assurance, Fraud Management and Interconnect Billing System was deployed, PLAY’s BI team realized the opportunity to link usage data records to marketing, sales and activation data to provide broader business insight in near real time. This provides an audit on their data warehouse, allowing them to have greater confidence in their BI analyses. More importantly, it gives PLAY a view of its network every 30 minutes and provides an understanding of geographical traffic distribution down to individual base stations and of the calling pattern throughout the day. Because PLAY can see where customers are calling and buying, they can rapidly adjust to the traffic impact of emergencies such as a snowstorm. Additionally, PLAY is able to make fact-based adjustments to its operations in a matter of hours instead of days or weeks which are typical in the wireless industry. This capability, envisioned and designed by PLAY, has enabled uncommon business agility, further cementing PLAY as the most innovative and responsive provider in the market. “We designed and implemented our analytic infrastructure to create a competitive advantage, by buying best-in-class software including the Lavastorm Analytic Platform, and by leveraging that software in as many creative ways as possible,” stated Hans Cronberg, Chief Technology Officer (CTO) of PLAY. “Our investment in MDA’s powerful near-real-time data analytic platform allowed us to create an infrastructure that we could leverage as we built our business intelligence assets. We appreciate the power of their platform and their continued commitment to innovate with us as we grow our business. This capability contributes to our ability to maintain margins and grow revenue as we grow our subscribers to over 3 million by year-end.” PLAY’s near real-time process analytic solution was created by directly integrating MDA’s Lavastorm Analytic Platform with the mobile operator’s BI environment. The solution takes advantage of four new Lavastorm Analytic Platform capabilities: advanced enrichment modules to enhance call data records (CDRs) with customer and operational data which makes them immediately usable in a BI environment; agile data aggregation that enables customers to design and execute any data combination easily and rapidly; CDR correlation that enables the reconciliation of CDRs flowing from different systems, and custom batch which sends results to the BI environment within minutes of the event. “We are pleased to support PLAY’s vision of a near-real time data analytic infrastructure to accomplish many mission critical business analytic functions with the same platform” stated Drew Rockwell, Chief Executive Officer (CEO) of MDA. “We see continued market evidence that global operators are looking to purchase platforms that can provide a broad range of solutions from a single infrastructure, rather than to manage multiple point solutions. The Lavastorm Analytic Platform can be provided in near real time, and is broadly extensible across business processes, and we are delighted to see these attributes valued and effectively deployed by PLAY and other MDA customers.” Press contacts: Martin Dawes Systems +44 (0)1925 555 300 www.martindawessystems.com

innkapNews - 18 December, 2009 - InnovationsKapital: Microdata raises 10 million SEK to fund international expansion

2010-01-18 16:39:07

Microdata Telecom Innovation AB is raising 10 million SEK from venture capital firm InnovationsKapital and from existing shareholders through an equity issuance. Microdata Telecom is currently expanding internationally to address a rapidly growing global market for Microdata Advanced Site Solutions ( MASS™ ) in the mobile infrastructure market. Through this equity infusion, we are able to further expand our marketing and sales internationally with our portfolio of state of the art radio products within Advanced Site Solutions says Mats Gustavsson, CEO and co-founder of Microdata. We believe that InnovationsKapital will be a valuable partner as we grow the company. Microdata is led by an impressive team with solid experience both from the industry and from building companies, says Martin Falkevall from InnovationsKapital. We have been impressed by their early customer traction and are looking forward to an exciting journey together with the company in the coming years For further information, please contact: Mats Gustavsson CEO Microdata Telecom Innovation AB +46 708 15 69 25 mats.gustavsson@microdata.se Martin Falkevall InnovationsKapital Nordic Advisor AB +46 8 54 50 14 90 martin.falkevall@innkap.se Linda Höljö InnovationsKapital Nordic Advisor AB +46 8 54 50 14 90 linda.holjo@innkap.se Microdata Telecom Innovation AB offers cost effective radio solutions to OEMs and Network Operators, in order to improve radio coverage, capacity and quality of mobile communications. The company has offices in Täby, Sweden and in India. For further information, please visit: www.microdata.se InnovationsKapital was founded in 1994 as an independent private equity/venture capital firm focused on investments in growth companies. Our investment strategy is to invest in technology companies in the Nordic countries. InnovationsKapital has invested in over 60 companies and Carmen Systems, Formex, Kreatel, Nordnav and Spotfire are some examples of successful exits. InnovationsKapital currently advises four venture funds aggregating over 3 billion SEK (or about 300 million Euro), raised from well renowned Swedish and international institutional investors. For further information about InnovationsKapital, please visit our webpage: www.innkap.se

innkapNews - 8 December, 2009 - InnovationsKapital: Medius is raising external capital to fund international expansion

2009-12-08 09:20:21

Medius, which prior to the equity issuance had been owned by management and personnel, has grown organically and profitably every year since its founding in 2002. The last three years (2006-2008), the company’s revenue has increased by 430% and is on target to reach 90 million SEK (or about 9 million Euro) in 2009. A strategic plan for 2010-2012 includes offering part of the company’s products in non-domestic markets, and in 2012, 40% of revenue is planned to come from markets outside of the company’s home country. Medius is a well established company in Sweden with over 300 customers, including, among others, Saab, Haldex, Stadium, Mekonomen, K-rauta, and The Body Shop. This equity injection gives the company the opportunity to continue its rapid expansion in the rest of the Nordic countries, the Netherlands, Germany, the UK, and in France. Through this equity infusion, we are able to carry out the expansion plans that we have for the upcoming three years. We see an enormous market opportunity for our workflow platform offering, MediusFlow, in markets that we are planning to expand into in the years 2010 through 2012. Given that we in only a matter of a few years have become market leading in Sweden within certain applications – for example support for the purchase to payment process, where support for handling of invoicing has been wildly successful – we are confident that this international expansion will be successful as well, says Per Nordling, CEO and co-founder of Medius. We have been in discussions with a number of venture capital firms, and realized early on that InnovationsKapital was the best partner for Medius at this time. Through their prior investments they have shown good judgment and they take a long term perspective, Per Nordling continues. Medius has all the attributes that we look for in new investments – a great team, a strong and competitive customer offering, and a fast growing market, say Peder Holm and Fredrik Cronqvist from InnovationsKapital. We are looking forward to helping Medius and the existing shareholders in this upcoming expansion. For further information, please contact: Per Nordling CEO Medius AB +46-13-12 16 30 per.nordling@medius.se Peder Holm InnovationsKapital Nordic Advisor AB +46-8-54 50 14 90 peder.holm@innkap.se Fredrik Cronqvist InnovationsKapital Nordic Advisor AB +46-8-54 50 14 90 fredrik.cronqvist@innkap.se Medius aspires to deliver the world‘s best business system support covering all aspects from the requirement setting phase to, and including, the administration phase. This span is dealt with in three business areas: Consulting, ERP, and Workflow. For the Nordic market, Medius works within all three business areas. In the markets outside of the Nordic countries, Medius primarily focuses on the offerings of the Medius workflow business area, i.e. Workflow™. Medius is currently represented in Sweden (headquarters), the Nordic countries, the Netherlands, Germany, the UK, France, United Arab Emirates, and in Poland. Through our global partners we reach organizations all over the world. For further information, please visit: www.medius.se InnovationsKapital was founded in 1994 as an independent private equity/venture capital firm focused on investments in growth companies. Our investment strategy is to invest in technology companies in the Nordic countries. InnovationsKapital has invested in over 60 companies and Carmen Systems, Formex, Kreatel, Nordnav and Spotfire are some examples of successful exits. InnovationsKapital currently advises four venture funds aggregating over 3 billion SEK (or about 300 million Euro), raised from well renowned Swedish and international institutional investors. For further information about InnovationsKapital, please visit our webpage: www.innkap.se

companyNews - 4 December, 2009 - SantarisPharma: New data show breakthrough microRNA-targeted therapy developed using Santaris Pharma A/S proprietary LNA technology holds promise as new treatment for Hepatitis C

2009-12-07 16:39:39

Hoersholm, Denmark/San Diego, California, December 3, 2009 — A study published online in this week’s Science shows that SPC3649, a breakthrough microRNA-targeted therapy developed by Santaris Pharma A/S using its proprietary Locked Nucleic Acid (LNA) technology, holds promise as a novel treatment for patients infected with the Hepatitis C virus (HCV). The World Health Organization estimates about 3% of the world’s population has been infected with HCV and that some 170 million are chronic carriers at risk of developing liver cirrhosis and/or liver cancer[1]. Approximately 3-4 million Americans are chronically infected with an estimated 40,000 new infections per year[2]. In Europe, there are about 4 million carriers[3]. Santaris Pharma A/S, the first company to have advanced both mRNA and microRNA targeted drugs into clinical trials, is an international biopharmaceutical company focused on the discovery and development of RNA-targeted therapies for a range of diseases including metabolic disorders, infectious and inflammatory diseases, cancer and rare genetic disorders. In this preclinical study, SPC3649 successfully inhibited miR-122, a liver-expressed microRNA important for Hepatitis C viral replication. By inhibiting miR-122, SPC3649 dramatically reduced Hepatitis C virus in the liver and in the bloodstream in chimpanzees chronically infected with the Hepatitis C virus[4]. Four HCV chronically infected chimpanzees were treated weekly with 5 or 1 mg/kg of SPC3649 for 12 weeks followed by a treatment free period of 17 weeks. The two animals that received the 5 mg/kg dose had a significant decline in viral levels in the blood and liver of approximately 2.5 orders of magnitude or approximately 350 fold[5]. “In collaborating with Santaris Pharma, we proved that the drug worked exceptionally well in treating HCV infections in chimpanzees,” said Robert Lanford, Ph.D., a scientist at the Southwest Foundation for Biomedical Research and one of the lead authors on the study. “The current standard anti-HCV treatment, which combines pegylated interferon-alpha with ribavirin, is effective in only about 50% of patients and is often associated with severe side effects. Because of the unique mechanism of action of SPC3649 and its tolerability profile, this new therapy could have the potential to replace interferon to treat disease progression or be combined with current treatments.” SPC3649 provided continued efficacy in the animals up to several months after the treatment period with no adverse events and no evidence of viral rebound or resistance, an important factor that distinguishes SPC3649 from direct antiviral HCV therapeutics. Current antiviral therapies that target the virus directly are challenged as the HCV continually mutates to develop resistance to treatment. Because SPC3649 inhibits miR-122, an important microRNA involved in HCV replication, the HCV is blocked from replicating without the apparent selection of resistant mutants. SPC3649 has other important properties that make it attractive as a therapeutic agent for HCV. The preclinical data show changes in the expression of key genes that may help patients who do not respond to interferon treatment to become responsive. SPC3649 is the first microRNA-targeted drug to enter human clinical trials and is currently undergoing Phase 1 clinical studies in healthy volunteers. These preclinical data provide even greater impetus to further examine the potential of SPC3649 for treating patients infected with HCV. “Advancing the first microRNA-targeted therapy, SPC3649, into human clinical trials was certainly a breakthrough in science and we are very encouraged by these preclinical findings demonstrating that SPC3649 has the potential to be an effective treatment for patients infected with the Hepatitis C virus,” said Henrik Ørum, PhD, Vice President and Chief Scientific Officer of Santaris Pharma A/S. “In drug discovery and development programs internally and with our partners, we continue to demonstrate that our proprietary LNA Drug Platform is fundamental in developing effective RNA-targeted therapies with high affinity, target specificity and remarkable potency for a range of diseases.” Santaris Pharma A/S has a robust product pipeline based on its proprietary LNA technology including mRNA and microRNA drug discovery and development partnerships and collaborations with Shire (rare genetic disorders), Wyeth, now part of Pfizer, (delivery of lead candidates against up to ten targets), GlaxoSmithKline (four viral disease drug candidates) and Enzon Pharmaceuticals (eight cancer targets successfully delivered). About Locked Nucleic Acid (LNA) Drug Platform The Locked Nucleic Acid (LNA) Drug Platform developed by Santaris Pharma A/S creates synthetically modified chemical versions of the normal nucleic acid building blocks of ribonucleic acids (RNA). These modified chemical versions called LNAs improve the drug-like qualities of resulting therapeutics (oligonucleotides) by improving affinity to their target RNA, boosting resistance to metabolism and improving tissue uptake. Upon systemic administration of these “naked” molecules, LNA-based therapeutics are delivered to many different tissues where they show potencies many-fold better than other oligonucleotide therapeutics. About Santaris Pharma A/S Santaris Pharma A/S is a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies. The Company’s proprietary Locked Nucleic Acid (LNA) drug platform, in combination with its highly specialized and targeted drug development capabilities, offers potential partners pre-screened drug candidates for commercial consideration across a multitude of disease states. The Company’s own research and development activities focus on infectious diseases and metabolic disorders while partnerships with major pharmaceutical companies include a range of therapeutic areas including cancer, rare genetic disorders and inflammatory diseases. Santaris Pharma A/S, founded in 2003, is privately-held and headquartered in Denmark with operations in the US. The Company has strategic partnerships with Enzon Pharmaceuticals, GlaxoSmithKline, Wyeth Pharmaceuticals (now part of Pfizer) and Shire plc. Please visit www.santaris.com for more information. Media Contact: Navjot Rai Santaris Pharma A/S Office: + 1 858 764 7064 ext. 206 Cell: +1 619 723 5450 navjot.rai@santaris.com [1] World Health Organization - www.who.int/csr/disease/hepatitis/Hepc.pdf [2] American Association for the Study of Liver Diseases - www.aasld.org/patients/Pages/LiverFastFactsHepC.aspx [3] World Health Organization - www.aasld.org/patients/Pages/LiverFastFactsHepC.aspx [4] The chimpanzee is the only animal other than humans that is susceptible to HCV [5] Lanford et al, Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection, Science online

companyNews - 2 December, 2009 - Ignis: Ignis completing private placement of NOK 13.5 million

2009-12-07 16:15:02

The board of directors of Ignis has resolved to issue 3 million new shares in a private placement to a financial investor. The shares will be issued at a price of NOK 4.50, resulting in gross proceeds of NOK 13.5 million. The shares are being issued pursuant to an authorization granted at the annual general meeting on 15. May 2009. The net proceeds will be used to fund operational initiatives and increased working capital requirements resulting from a strong demand growth. New share capital will be NOK 106 068 315, distributed amongst 42 427 326 shares. The new shares will be tradable as soon as the share issue has been registered in the Norwegian Register of Business Enterprises. On 11. November 2009, Ignis and GC Holdings, Inc. ("Gemfire”) entered into an exclusive term sheet for a business combination to form a market leader in the international market for integrated optics. The completion of the transaction was subject to i.a. completion of satisfactory due diligence investigations, final negotiation of mutually acceptable terms and a definitive agreement for the transaction, and approval of the transactions by an extraordinary general meeting of Ignis. The process continues and Ignis is still considering a combination with Gemfire as strategically very attractive. A revised time plan and update on the transaction will be communicated to the market in due course. The USD 3 million loan option from Palo Alto Investors contemplated by the term sheet will not be exercised. Hence the above described private placement will allow Ignis to meet near term financial requirements. The private placement is a purely financial transaction, and is in no way incompatible with a strategic transaction. In effect, this strengthens the balance sheet and will improve the ability to carry out a successful strategic transaction. About Ignis Ignis ASA is an international technology company delivering active and passive optical components for cost effective transportation of data. Ignis ASA comprises of three subsidiaries including 69.3% ownership in Ignis Fira in Korea, the wholly owned Ignis Photonyx in Denmark and Ignis Syntune in Sweden. Ignis Fira is first and foremost provider of optical splitters to large system houses and telecom operators in Asia, while Ignis Photonyx over the last years has been focusing on investing in the development of AWG`s for the next generation high-capacity broadband network WDM-PON. Ignis Syntune supplies state-of-the-art widely tunable lasers for applications ranging from fiber-optic communications to sensor systems. Ignis ASA is headquartered in Oslo Norway and is listed on Oslo Stock Exchange (OSE: IGNIS). For further info please contact: Thomas Ramm Ignis ASA Chief Executive Officer Tel: +47 913 70 795 thomas.ramm@ignis.com Walker Kinman Ignis ASA Chief Financial Officer Tel: +46 70 722 6513 walker.kinman@ignis.com This announcement does not constitute an offer to sell, or an invitation to purchase, any securities. The distribution of this announcement and other information in connection with the Private Placement may be restricted by law in certain jurisdictions. Persons into whose possession this announcement or such other information should come are required to inform themselves about and to observe any such restrictions. This announcement is not an offer to sell or the solicitation of any offer to buy any Ignis shares or other securities of Ignis (the “Securities”) in the United States, nor shall there be any sale of the Securities in any state thereof in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The Securities may only be offered and sold in the United States pursuant to an effective registration statement filed with the United States Securities and Exchange Commission or pursuant to an exemption from the registration and prospectus delivery requirements of the United States Securities Act of 1933, as amended. Any public offering of the Company's securities in the United States will be made only by means of a prospectus that may be obtained from the Company and that will contain detailed information about the Company and management, as well as financial statements and other information relevant to investors. This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)

companyNews - 1 December, 2009 - Apptus: One of the leading European supplier of IT infrastructure Atea chooses Apptus to create a more intelligent e-commerce solution

2009-12-07 16:11:17

Atea, the leading Nordic and Baltic supplier of IT infrastructure products and services, have chosen Apptus to develop a more intelligent solution for their e-commerce system on the Nordic and Baltic market. With the improved system Atea will be able to automatically change the content of the site for specific users with individual product, price and shipping agreements. ”We conducted a thorough evaluation of all the suppliers on market and found that Apptus (with its competence and the resources) is the best alternative to deliver a solution that met our needs, timeframe and budget.” says Zlatko Ninic, CIO at Atea. With Apptus solution, customers that log in to Ateas eSHOP only gets access to those products or price- and shipping agreements that are valid for their company, organization or government. The system filters the database in realtime and thereby the user automatically searches within the relevant products. The system will also be able to suggest products according to the individual company's search- and buying history. “To create a solution that has the capacity to manage the large amount of customers, agreements and products in Atea's database, it is vital that you have an advanced system that can handle a multitude of relations in realtime.” says Michael Mokhberi, CEO at Apptus. ”Apptus' solution was very comfortable. We already had a functional e-commerce solution and a comprehensive material of business data, but they easily integrated their solution with our system.” says Zlatko Ninic. For more information, please contact: Michael Mokhberi, CEO at Apptus Mobile: +46 701664102 michael.mokhberi@apptus.com Apptus idea is to bring buyers and sellers closer to each other by providing instant access to relevant information. Since year 2000 the company has developed solutions based on the platform Theca, which optimizes the synergies between search, content and sales. Apptus is a private company, headquartered in Sweden with sales organizations in Europe and North America. Among the customers are leading companies within e-commerce and online directories in 18 countries, for example ATEA, Bokus, CDON, De Gule Sider, Eniro, Fonecta, Hitta, Lokaldelen, Panduro Hobby, Quebecor, Truvo and Yell.com. For more information, please visit www.apptus.com Atea is the leading Nordic and Baltic supplier of IT infrastructure products and services. Atea has approximately 4 400 employees and is present in 71 cities in Norway, Sweden, Denmark, Finland, Lithuania, Latvia and Estonia. Atea has an annual revenue of approximately NOK 15 billion and is listed on the Oslo Stock Exchange. For more information, please visit www.atea.com

companyNews - 30 November, 2009 - Virtutech: Virtutech Expands International Growth by Opening China Subsidiary

2009-12-07 16:07:06

SAN JOSE, Calif.— November 30, 2009— Virtutech®, Inc., the leader in virtualized systems development (VSD), today announced that it has established a subsidiary in China to support its expanding customers and partners. Based in Shanghai, Virtutech Ltd. will provide a direct channel to regional businesses and enhance support for existing Simics customers in the Asia Pacific market. Virtutech Ltd. is part of the company’s continuing global expansion strategy, and reflects its commitment to deliver the most advanced virtual platform and simulation-based solution to OEM and semiconductor companies who recognize that virtualization of development is the necessary breakthrough to overcome technical and business challenges. “Virtutech Ltd. extends our commitment to supporting Simics users and partners throughout China,” said Greg Lund, vice president, Asia Pacific Region, Virtutech, Inc. “Our comprehensive approach to electronics systems design, and to driving the adoption of VSD will lower project risk and improve the quality of software products in the thriving Chinese market.” Virtutech has been growing its business in China since 2007, when it partnered with several Chinese and American based companies and organizations, including, Freescale, Huawei, Power.org, RMI, Tensilica, Vision Microsystems and Wind River. Demand for Simics has been especially strong in China, where the rapid growth of the embedded software industry has created the need for a solution that fully leverages multi-core architectures, and runs complex simulations of semiconductor and OEM environments. Customer and Partner Response “Freescale recognizes the importance of its partnership with Virtutech. The Simics VSD platform provides an essential component for the success for our QorIQ and P4080 processor eco-system development,” said Raja Tabet, vice president software and enablement at Freescale. “We welcome Virtutech’s continued investment in China as a necessary step to further streamlining and promoting the migration to multi-core architectures.” “Huawei has traditionally invested in technologies that enable it to rapidly bring high quality products to support the deployment of All-IP networks for operators worldwide by dramatically improving engineering productivity. We believe simulation is the key to advanced system development, and Simics is by far the leading solution,” said Mr. Zhou, vice president, Huawei Wireless Product Line. “We are committed to simulating the entire software architecture before hardware is available to further reduce product development time and Virtutech’s Simics will be the cornerstone of this initiative.” “Power.org considers Virtutech a valuable partner, and one the industry’s foremost providers of technology that can speed development time and ensure systems are prepared to meet increasing demands for performance and scalability,” said Fawzi Behmann, director of marketing at Power.org. “Virtutech’s growth in China’s supports and promotes the region’s adoption of Power Architecture technology within the design community by providing a powerful tool to break down barriers in innovation.” “Simics’ support of RMI Corporation’s advanced XLR® and XLS® MIPS64 multi-core and multi-threaded processor cores enables developers to create fast, virtual models of sophisticated RMI-based platforms that can connect with additional boards and complete racks of equipment across standard networks,” said Mark Litvack, director of business development, RMI. “This provides us with the ideal tool to further extend support for our Chinese customers as it is no longer necessary to wait until the hardware is available before defining, developing and deploying key OS, applications and systems software.” “Tensilica has a long-established and rapidly growing presence in China, and we welcome our partner Virtutech's expanding reach within the region,” said Sam Wong, Tensilica’s director of Asia Pacific region. “This move will help offer to Chinese developers of multiprocessor SoCs a complete VSD platform incorporating models of Tensilica's customizable dataplane processors that can accelerate the design cycle and time-to-market.” “Our customer base demands high-performance and efficient solutions to improve the production of complex and innovative software,” said David Zhang, President of Vision Microsystems Co., Ltd. “With Virtutech Simics, we offer our aerospace and defense, consumer, telecommunications, network equipment and automobile industry customers a tightly integrated environment to meet the breadth and scale for our customers embedded system development needs.” “Virtutech’s Simics was a key technology in the development of VxWorks and Wind River Hypervisor. Pre-silicon development has reduced our development risk and cut cost and time in developing the software that powered our advanced multi-core-optimized embedded operating systems,” said Emeka Nwafor, director of product management, Wind River. “Our experience has been that applying VSD has improved the effectiveness of our development and testing activities and streamlined the development of these intricate run-times.” About Simics Simics is a high performance full-system simulator that enables engineers to develop, debug, test and run their entire software application stack on a virtual representation of their target hardware named virtual platform. The overall engineering development efforts are reduced through advanced capabilities normally not available with physical hardware: non-invasive debugging and tracing, saving and later resuming execution, full deterministic behavior, built-in networking capabilities, forward and reverse execution, ability to examine, control, and break on any internal device and to inject faults, and the ability to save system state and later replay it. Simics runs unmodified production-quality binaries and can be used with third party software development tools. About Virtutech Virtutech, Inc. is the leader in product development process improvement through virtualized systems development (VSD). Virtutech Simics® allows for a revolutionary change in the product development process at a full system level rather than a component level and is the only commercial solution that delivers the four most important criteria for successful deployment of hardware virtualization in the electronics equipment development process: speed, scalability, model availability, and control. Simics customers report reduced time to market, better project risk management, lower capital expenditure, product development cost and maintenance as well as increased quality and individual productivity. Virtutech serves the needs of the world’s leading OEMs in the high-performance computing, aerospace and defense, telecommunications, networking and semiconductor industries. Customers include Cisco, Ericsson, Freescale Semiconductor, GE Avionics, Honeywell, IBM, Lockheed Martin, Nortel, Northrop Grumman, MontaVista Software and Wind River. Virtutech is an active participant in organizations to drive adoption of VSD such as ARM Connected Community, Eclipse.org, IBM PartnerWorld, Multicore Association, Power.org, OSCI and Spirit Consortium. Virtutech is headquartered in San Jose, Calif. For more information, visit www.virtutech.com Media Contacts: Schwartz Communications, Inc. Merrill Freund 415.512.0770 virtutech@schwartz-pr.com Virtutech, Inc. Michel Genard 408.392.9144 mgenard@virtutech.com

innkapNews - 4 December 2009 - InnovationsKapital: PBM Sweden AB and InnovationsKapital initiate a long-term relation where InnKap 4 Partners LP initially invests SEK 7.5 million.

2009-12-07 15:55:17

Customers are mainly county councils, insurance companies and private companies. ”InnovationsKapital is a serious, long term and stabile investor with a strong track record of helping companies grow and realise their potential”, says the senior consultant Nils Edelstam (M.D.), PBM. PBM is currently based in six cities - Stockholm, Göteborg, Malmö, Gävle, Hudiksvall and Söderhamn. PBM plans to start further business in Sweden and the other Nordic countries. InnovationsKapital invests in young Nordic companies within the Healthcare & Life Sciences and ICT sectors. ”PBM is a very qualified company that continuously delivers excellent and lasting results to its customers. We are convinced that they will grow rapidly in this expansive market”, says Gunnar Fernström being responsible for InnovationsKapital’s investment in PBM. In total InnKap 4 Partners LP will invest up to SEK 19 million in this round of finance. For more information, please contact Tina Nikolaidou, Market Director, PBM, +46 70-569 28 82, www.pbm.se Gunnar Fernström, Investment Director, InnovationsKapital +46 70-312 05 02 gunnar.fernstrom@innkap.se www.innkap.se InnovationsKapital InnovationsKapital was founded in 1994 and is a private and independent early stage venture capital firm for innovative growth companies. The business, carried out from offices in Gothenburg and Stockholm, is focused on Nordic investments within ICT and Healthcare & Life Sciences – dynamic sectors that are rapidly expanding and where Nordic research plays an important role. To date, over 65 investments have been made. Successful exits include Altitun, Arexis, BioInvent/Alligator, Carmen Systems, Kreatel Communications, NordNav and Spotfire. InnovationsKapital advises four venture capital funds aggregating EUR 323 million in committed capital. The capital is provided by highly reputable Swedish and international institutional investors. Further information about InnovationsKapital can be found at www.innkap.se

innkapNews - 30 June 2009 - InnovationsKapital: Projectplace’s new owners reinforces European strategy

2009-07-06 15:02:14

On Friday June 26, 2009, Projectplace International AB, Europe’s leading online project collaboration tool, was acquired by three venture capital companies. The buyers all have prior relationships with the company and good insight and understanding of its business. The ownership change is a step in the company's continued development and strengthens its future opportunities. - “We are already well established as the market leader in Sweden and Norway and are growing rapidly in Germany and the Benelux region. The new ownership provides us the ability to continue strengthening our position in existing markets while expanding in new European markets”, says Pelle Hjortblad, CEO, Projectplace International. Projectplace International’s business has been growing 30% per year the last three years. The turnover amounted to SEK 129 million in 2008. With the new owners on board the company see a strong opportunity for continued rapid expansion through organic growth as well as strategic acquisitions. - “We have had an eye on Projectplace International for a while”, says Anders Grånäs, Via Venture Partners. “When we got the opportunity to complete this deal, it was a very easy decision for us. The process has been fast and all parties agree.” - “Projectplace International is an innovative, well-run company with high development potential”, says Anders Ösund, Investor Growth Capital. “As an existing owner, we have followed the company for many years. With a clear Europe focused strategy, the company has a great opportunity to increase its growth rate further in coming years.” Investor Growth Capital, Via Venture Partners and InnovationsKapital will each own 30% of the company. The remaining 10% will be offered to a number of key employees within the company - “We are very pleased that the company's management and key employees want to invest and thereby take an active part in the company's continued development. We strongly believe that Projectplace has great potential and are very happy that the management clearly feels the same way”, says Magnus Berglind, InnovationsKapital. Contact: Projectplace International, Pelle Hjortblad, CEO, tel. +46 701810110 Investor Growth Capital, Anders Ösund, tel. +46 73 5241824 Via Venture Partners, Anders Grånäs, tel. +46 734441001 InnovationsKapital, Magnus Berglind, tel. +19175820396 Public Relations Projectplace International: Anna Ålenius Mathson, PR Manager Tel: +47 708 93 02 46, email: anna.alenius.mathson@projectplace.com Since 1998, Projectplace International has developed and provided Europe's leading web tool for project collaboration. The company, with 100 employees, is based in Stockholm, Sweden, with local offices in Denmark, Germany, The Netherlands, and Norway. For more information, please visit www.projectplace.com

innkapNews - 18 April, 2009 - InnovationsKapital: Ignis ASA Acquires Syntune AB

2009-04-20 11:37:18

The acquisition will widen the Ignis product range to include active components, and together with the existing passive components portfolio provide a broader optical offering to network operators. Ignis will issue 8.05 million shares as compensation for 100 % of the shares in Syntune AB to the sellers, which include the leading institutional investors InnovationsKapital and Vision Capital, and founders. Syntune will have a cash position of approximately SEK 25 million prior to the acquisition, and interest bearing debt of approximately SEK 41.8 million. In addition Syntune has established a new loan facility of EUR 2.3 million, Syntune's cash position is considered sufficient to fund its activities until break even during 2010. The company completed the qualification of its first generation of products in 2007. Ramp-up of revenue began at the end of 2007, and amounted to gross SEK 18 million in products sold in 2008, with a significant growth speed into 2009. With Syntune as a 100 % owned subsidiary, Ignis will strengthen its technology platform in a crucial area, tunable laser technology, and in addition get some of the best expertise in the optical industry. Tunability is becoming one of the most critical elements of the optical industry, as wavelength agility offers cost reductions and increased flexibility for optical network operators. Ignis ASA signed a Letter of Intent to acquire Syntune AB earlier in April. After the approval by the Board of Directors in Ignis, the acquisition remains contingent on approval by the General Meeting in Ignis ASA. By acquiring Syntune, Ignis maintains its strategy in taking an active part in the ongoing global industry consolidation. A detailed stock exchange notification about the transaction will follow on Monday the 20th of April. On the same day the company management will present further details about the acquisition at 10 am, at the Felix Conference Centre, Aker Brygge. The presentation will be published via webcast. See Ignis homepage. About Ignis ASA Ignis ASA comprises the business division Ignis Technology, which includes 69.3% ownership in Fi-ra Photonics in Korea and the wholly owned subsidiary Ignis Photonyx - with operations in Denmark, Norway and Canada. Fi-ra is first and foremost provider of optical splitters to large system houses and telecom operators in South-East Asia,while Ignis Photonyx over the last years has been focusing on investing in the development of AWG`s for the next generation high-capacity broadband network WDM-PON. About Syntune AB Syntune AB (www.syntune.com) supplies state-of-the-art widely tunable lasers for applications ranging from fiber-optic communications to sensor systems. In communications, Syntune's lasers enable universal DWDM transceivers with low power consumption in a small form factor. These drastically reduced overhead costs for sparing and maintaining inventories. Tunability also enables flexible networks, which allows operators to offer innovative services and reduces their operational expenditures. About InnovationsKapital InnovationsKapital is a leading independent venture capital firm in the Nordic region with capital commitments of EUR 317 million in four funds. Years of experience and a strong network within academia and industry enable us to invest in successful early stage and growth companies. We support talented entrepreneurs to help them create successful high growth businesses. Since 1994, we have made over 58 investments and a number of successful exits in the life sciences and technology sectors. For further information, please contact: Thomas Ramm, CEO, Ignis ASA Tel: +47 913 70 795

innkapNews - June 18, 2008 - InnovationsKapital: CapMan and InnovationsKapital invest in Crayon

2008-07-27 00:00:00

Crayon advises its clients in software procurement processes and simplifies the clients' software license administration. In addition Crayon offers consulting and training around the purchased software to its clients, which include a number of large Nordic customers within both private and public sectors. The company was founded in 2002 and it has headquarters in Oslo and offices in Trondheim, Stockholm, Umeå, Copenhagen and Helsinki. Crayon's net sales totalled some MEUR 48 in 2007 and the company employs some 190 people. “The company has a truly unique offering in software asset management, combining the work normally done by a value added reseller with skilled management consulting, which has resulted in a strong growth in sales and very satisfied customers”, says CapMan's Investment Director Julia Reuszner. “Crayon has a very strong market position both in Norway and Sweden and we believe there is potential to develop this further and address new geographies and a wider customer base”, says InnovationsKapital's Investment Director Martin Falkevall. “For us the investment made by CapMan and InnovationsKapital is a great acknowledgement of what Crayon has achieved over the last years .We believe that the investment can help us to the next level in our growth ambition”, says Crayon's Chairman of the Board Jens Rugseth. CapMan Technology 2007 fund and InnovationsKapital will own 20% of Crayon's parent company Artix's shares with equal holdings after the transaction has been completed. The current owners, including management and employees, will hold the reminder of the shares. The closing of the transaction is subject to certain conditions agreed with the parties in the transaction to be met. CapMan Plc is a substantial investor in CapMan Technology 2007 fund. For more information, please contact: Julia Reuszner, Investment Director, CapMan Technology tel. +46 8 545 854 70 or +46 739 865 664 Martin Falkevall, Investment Director, InnovationsKapital tel. +46 8 54 50 14 90 or +46 708 47 73 16 Jens Rugseth, Chairman of the Board, Crayon tel. +47 22 89 10 00 or +47 91 16 94 40 CapMan www.capman.com CapMan is one of the leading alternative asset managers in the Nordic countries and manages Nordic funds with approximately EUR 3.1 billion in total capital. CapMan has five investment areas (CapMan Buyout, CapMan Technology, CapMan Life Science, CapMan Russia and CapMan Real Estate), and each of them has a dedicated team and funds. Altogether CapMan employs 130 people in Helsinki, Stockholm, Copenhagen, Oslo and Moscow. CapMan was established in 1989 and its B shares are listed on the Helsinki Stock Exchange since 2001. InnovationsKapital www.innkap.se InnovationsKapital is a leading independent venture capital firm in the Nordic region with capital commitments of EUR 317 million in four funds. Years of experience and a strong network within academia and industry enable us to invest in successful early stage and growth companies. We support talented entrepreneurs to help them create successful high growth businesses. Since 1994, we have made over 58 investments and a number of successful exits in the life sciences and technology sectors. Crayon www.crayon.no Crayon is a successful provider of software asset management and licenses, consulting services and training courses. Established in 2002, Crayon has operations in Norway, Sweden, Finland and Denmark and employs 190 people.

innkapNews - July 8, 2008 - Xtract: Xtract, Innovator in Social Advertising Intelligence Raises EUR 7.5 Million

2008-07-08 00:00:00

London, UK and Helsinki, Finland – July 8, 2008: Xtract, the leader and innovator in social advertising intelligence today announced that it has closed its series B round of funding with EUR 7,5 Million ($11.74M) from leading early-stage technology investors Creandum, ETF III advised by Eqvitec Partners and InnovationsKapital. Xtract enables mobile and online companies to refine their customer data creating highly accurate 3 Dimensional profiles combining social interactions, behaviour and demographic information. It answers a crucial need in the advertising industry by making the advertising in social media and mobile effective. By using Xtract, customers have seen the average ad income increase with as much as 82% and in mobile campaigns response rates have increased, on an average, with 30%. Staffan Ingeborn, Managing Investment Director of InnovationsKapital comments: “Xtract is a very exciting company with a unique proposition for targeting of digital advertising. Its solutions have been shown to create substantial value for its customers, and we believe that Xtract is very well positioned to become a winner and a leader in this space.” Xtract works with over 50 companies with intensive customer data ranging from global leaders such as Nokia, T-Mobile and Vodafone to innovative challengers such as BLYK and Flirtomatic. Xtract makes complexity simple and actionable via a unique and patented set of products that based upon social interactions, behaviour data and other dataflow can create accurate and dynamic real-time customer profiles. Xtract can ensure delivery of the right audience to the right commercial message at the right time and accurately report on the effectiveness of any campaign. Something which up until now was not possible. Xtract board member Juha Mikkola of Eqvitec Partners said: “This investment opportunity had a lot of demand and clearly marks the very interesting market and expansion opportunity that Xtract represents in the fast growing social intelligence market.” “We are delighted to have added two new prominent investors, InnovationsKapital and Creandum in addition to our original investor ETF III advised by Eqvitec Partners. This investment round combined with an exceptional organic growth enables us to expand to new markets outside Europe,” says Kimmo Kiviluoto, CEO of Xtract. About Creandum Creandum is a Nordic venture capital firm investing in early-stage technology companies. The firm has 120 million Euros under management and is today the fastest growing independent partnership of its kind in the Nordic region. Creandum invests in innovative companies in high growth markets led by outstanding entrepreneurs. All investment professionals at Creandum have started companies or been part of successful startups. For more information, please visit www.creandum.com About Eqvitec Partners Oy Eqvitec Partners Oy is one of the largest technology focused venture capital and private equity firms in Northern Europe. The company was founded in 1997 and employs 15 investments professionals in Helsinki and Stockholm. Eqvitec Partners currently advises 6 funds with the total capital base of 500 million Euros. The funds invest in technology companies in all phases from start-up to buyouts. At the moment the funds have investments in 40 companies and have carried out 35 exits. More information can be found at www.eqvitec.com About InnovationsKapital InnovationsKapital is a leading independent venture capital firm in the Nordic region with capital commitments of EUR 317 million in four funds. Years of experience and a strong network within academia and industry enable InnovationsKapital to invest in successful early stage and growth companies. InnovationsKapital supports talented entrepreneurs to help them create successful high growth businesses. Since 1994, InnovationsKapital has made over 60 investments and a number of successful exits in the life sciences and technology sectors. For more information, please visit www.innkap.se About Xtract Xtract is the global trusted partner and innovator in Social Advertising Intelligence. We have the technology and competence to turn large user data into cash flow. Our solutions create accurate and automated consumer profiles for mobile and online advertisers based on social interactions, behavioural and demographic data. Xtract operates across Europe and Asia, working with over 50 companies with intensive customer data ranging from global leaders such as Nokia, T-Mobile and Vodafone to innovative challengers such as BLYK and Fonecta. Headquarters are in Helsinki, Finland and London, UK. www.xtract.com

innkapNews - June 27, 2008 - InnovationsKapital: Isconova secures 30 million Swedish kronor growth financing

2008-06-27 00:00:00

Leading vaccine adjuvant provider set to grow in animal vaccine market and to unlock the value of its technology for human vaccines. Uppsala, 27 June 2008. Isconova AB, announced today that it has secured financing of 30 million Swedish kronor ( 3,3 m€ ) from InnovationsKapital, a leading Nordic venture capital firm, and a group of private investors. Isconova is a pioneer in vaccine adjuvant technology, with a proprietary, safe and effective ISCOM technology. ”We are extremely pleased to have attracted the support of InnovationsKapital, who have a successful record of backing innovative growth biotech companies in Scandinavia. This new investment will allow Isconova to increase our production capacity and to invest in marketing,” said Bengt Falk, Isconova's CEO. “It will enable us to build on our existing growth in the animal vaccine sector. We will also be able to accelerate our activities in human vaccines where we already have a very promising partnership on an influenza vaccine.” Isconova's scientific excellence in the vaccine adjuvant field is backed by commercial validation through several agreements with major healthcare partners and on-market veterinary vaccines. “We feel excited about Isconova's future,” commented Johan Rask and Ulf Tossman at InnovationsKapital. Isconova's adjuvant makes vaccines more protective and longer-lasting. This fills a critical need for safe and effective adjuvants in the fast-growing vaccine industry. Isconova has established a significant production capacity in Uppsala and is already supplying its Matrix adjuvant to corporate partners for use in animal vaccines. For further information please contact: At Isconova: Bengt Falk, CEO, Isconova phone +46 703 022254 email bengt.falk@isconova.se At InnovationsKapital: Ulf Tossman, Investment Director, InnovationsKapital phone +46 705 630858 email ulf.tossman@innkap.se Johan Rask, Investment Manager, InnovationsKapital phone +46 708 946060 email johan.rask@innkap.se About Isconova AB, www.isconova.se Isconova, based in Uppsala, Sweden was established in 2000 by scientists from the Swedish Agricultural University. The Company's mission is to use its safe and effective ISCOM technology platform to deliver innovative vaccines. ISCOM is already established as the dominant vaccine adjuvant for horse vaccines in Europe. Isconova has licensed its technology to major vaccine corporations, including Intervet, Schering Plough, Pfizer and Crucell. Isconova will continue to drive growth by extending the use of its adjuvant into dogs, cats and livestock. New developments will allow Isconova to develop research projects to explore the use of ISCOM in human vaccines. About InnovationsKapital, www.innkap.se InnovationsKapital was founded in 1994 and is a private and independent early stage venture capital firm for innovative growth companies. The business, carried out from offices in Gothenburg and Stockholm, is focused on Nordic investments within ICT and Healthcare & Life Sciences – dynamic sectors that are rapidly expanding and where Nordic research plays an important role. To date, more than 60 investments have been made. Successful exits include Altitun, Arexis, BioInvent/Alligator, Carmen Systems, Kreatel Communications, NordNav and Spotfire. InnovationsKapital advises four venture capital funds aggregating EUR 317 million in committed capital. The capital is provided by highly reputable Swedish and international institutional investors.

innkapNews - June 11, 2008 - Syntensia: Syntensia Secures Expansion Financing - Leading Network Security-on-Demand Company Charts Further Growth in Emerging Markets

2008-06-11 00:00:00

NEW YORK, June 3, 2008 - Syntensia AB, a pioneer in subscription Network Security-On-Demand solutions, has secured financing of $3.5 million with an option for an additional $4 million through a share issue directed to InnovationsKapital, a leading Nordic venture capital firm, and a group of private investors in Sweden and abroad. Syntensia chairman is John Wattin. Syntensia, headquartered in Stockholm and with sales offices in twenty major Indian cities, Philippines and Cambodia was established in 2005 by Kaushik Thakkar. It focuses on providing all-in-one network security solutions for SMB in high growth emerging markets. "This investment allows Syntensia to continue our solid growth in India and our expansion in Cambodia and the Philippines," said Syntensia CEO Johan Hansson. "It also makes possible expansion into other Asian markets. We are particularly pleased to have attracted the support of InnovationsKapital, which has a reputation for backing innovative growth companies in Scandinavia." “Syntensia is capitalizing on the powerful combination of a low cost, high demand product offering to fast growing markets. We are very pleased with our investment in Syntensia and feel very excited about the company's potential,” said InnovationsKapital's Investment Director Magnus Berglind. Syntensia's WK product series is the most cost-effective and comprehensive network security solution for SMB available in the market today. These hardware-based appliances are Plug and Play ready, all-in-one network security solutions that integrate seven crucial security check points - Firewall, VPN, Intrusion Protection, Anti Virus, Spam Elimination, Surf Protection and Spyware Guarding and are available for a nominal subscription fee. Syntensia’s subscription model typically bundles everything into its single subscription fee, including automatic updates, maintenance and 24X7 technical support, thus enabling organizations to eliminate upfront costs, providing a predictable cost structure, and ensuring quality of service and the freedom to re-evaluate the solution decision any time. For further information please contact: Johan Hansson, CEO, Syntensia Phone: +1 917 582 0753 Email: johan@syntensia.com Magnus Berglind, Investment Director, InnovationsKapital Phone: +1 917 582 0396 Email: magnus.berglind@innkap.com InnovationsKapital InnovationsKapital (www.innkap.com) was founded in 1994 and is a leading independent venture capital firm for innovative growth companies in the Nordic region. The business, carried out from offices in and Stockholm, Gothenburg and New York, is focused on investments within ICT and Healthcare & Life Sciences – dynamic sectors that are rapidly expanding and where Nordic research plays an important role. The capital is provided by highly reputable Swedish and international institutional investors. Syntensia AB Syntensia AB (www.syntensia.com) is a European Company headquartered in Stockholm, Sweden. Established in 2005, Syntensia is a pioneer in Security on-demand solutions sold on subscription basis. Syntensia focuses on providing all-in-one network security solutions for SMB in high growth emerging markets.

innkapNews - Sept 24, 2007 - InnovationsKapital: Apptus expands with help of InnovationsKapital

2007-09-24 00:00:00

Apptus Technologies AB - a Swedish challenger in the global market for search technology in the e-directory and e-commerce sector - announced today that InnovationsKapital, the leading Nordic private equity/venture capital fund has become a new investor in the company. Since its founding in 2000, Apptus Technologies has positioned itself as the leader in the e-directory and e-commerce sector in the Nordic countries. As a result, Apptus' technology platform is currently used by top tier customers such as, Eniro, Hitta and CDON.COM. In collaboration with InnovationsKapital, Apptus will increase its efforts on international expansion, continue the strong focus on sales and broaden the Apptus product portfolio. "With InnovationsKapital in our corner, we can scale up operations and take aggressive measures to become a leading international player in search technology. We have recently won our first customers in England and Canada, and we see this as a springboard out into the world," says Apptus CEO Michael Atlevi. "Apptus is a very exciting company with a unique offering to its customers, as well as strong and proven products and an impressive Nordic customer base. We are looking forward work with the Apptus team to build on their already widely successful Nordic presence. We strongly believe Apptus has the potential to become a dominating player in the global marketplace," says Martin Falkevall, Investment Director at InnovationsKapital. "Apptus position in the Nordic market has improved dramatically during 2007. We continue building our world class team, expand our product line and increase sales by 70 percent this year. InnovationsKapital will take an active role on our board of directors, bringing a strong track record and extensive experience in international expansion. We are launching several major initiatives for which we are well-equipped, thanks to our stable foundation, both when it comes finances and expertise," says Gertrud Elisabet Bohlin, Chairperson of the Board, Apptus Technologies AB. For more information, please contact: Gertrud Elisabet Bohlin, Chairwoman of the Board, Apptus Technologies AB Phone: +46 705-669526 E-mail: geb@queenab.se Martin Falkevall, Investment Director, InnovationsKapital Phone: +46 708- 47 73 16 E-mail: martin.falkevall@innkap.se More about Apptus Apptus Technologies AB is leading in search and database technology in the Nordic countries. The company provides solutions and products that assure availability for customers with growing data volumes and stringent demands on search logic, relevant results and connections to customers' operations. Apptus primarily supplies solutions to customers in the e-directory and e-commerce sector. Among the Nordic customers are Bokus, CDON.COM, De Gule Sider, Eniro, Hitta.se, Lunarstorm, Sveriges Radio, Torget Sverige, etc. Apptus conducts research in search and database technology. Apptus stands for quality, results and growth. For more information, please visit http://www.apptus.com. More about InnovationsKapital InnovationsKapital was founded in 1994 and is a leading early stage venture capital firm for innovative growth companies in the Nordic region. The business, carried out from offices in Gothenburg and Stockholm, is focused on Nordic investments within ICT, Healthcare & Life Sciences and Clean Tech - dynamic sectors that are rapidly expanding and where Nordic research plays an important role. InnovationsKapital currently advises four venture funds aggregating EUR 320 million in committed capital. The capital is provided by international institutional investors. For further information, please visit http://www.innkap.se

innkapNews - June 13, 2007 - InnovationsKapital: InnKap finansierar gräddan

2007-06-13 00:00:00

Innovationskapital handplockas endast de bästa projekten den skandinaviska marknaden och inför framtiden hoppas Gunnar Fernström, som är partner Innovationskapital och ansvarig för Health Careinvesteringar, att kunna finansiera bolag som kan erbjuda ny medicinsk teknik för att kunna avlasta sjukvården. "Generellt sett finansieras i dag färre bolag men kvaliteten bland dem som når marknaden har blivit betydligt högre," säger Fernström. Sedan Gunnar Fernström startade på Innovationskapital 1998 har branschen förändrats i positiv riktning. "Det har hänt enormt mycket under de senaste tio åren. Förutom att vi i dag är mycket noggrannare med vilka objekt vi väljer att finansiera, så har också medvetenheten och intresset bland forskarna för att kommersialisera resultat av sin forskning ökat markant," konstaterar Gunnar Fernström. "1998 var det ganska få som visade intresse för att gå ut i bolag med sitt forskningsresultat. I dag tror jag att de allra flesta som arbetar med forskning i olika program känner till att det finns möjlighet att starta verksamhet och att deras forskning kan komma ut i bolag." Innovationskapital investerar i de mest intressanta bolagen, främst i Skandinavien, med ett perspektiv på 5-7 år men ibland längre. Bolaget erbjuder stor expertis och nätverkskontakter under hela investeringsoch utvecklingsprocessen. Endast de bästa bolagen handplockas. "Förutsättningen för en finansiering är att produkten möter ett riktigt bra medicinskt behov som inte någon annan tillgodoser. Det kan vara både inom medicinsk teknik, läkemedel eller diagnostik," säger Gunnar Fernström. Framtidens bolag "Framtiden tror jag handlar om att hitta terapier inom medicinsk teknik som kan avlasta sjukvården genom att förkorta vårdtider och förbilliga vård. Forskningsresultat som leder till att människor kan behålla god livskvalitet, trots hög ålder, är viktiga saker," framhåller Fernström och funderar över förutsättningarna för morgondagens bolag. Fernström menar att det skulle vara av nytta för företagarvärlden om det inom universitetens ram skapades mer utrymme för entreprenörsbiten. Det skulle i sin tur leda till att mognare bolag plockades upp av venture bolagen. "Mot slutet av 2000-talet var det många bolag som kom till marknaden utan att de var riktigt mogna. Med mer 'mjuka pengar' in i universitetssystemet för att klara av de initiala finansieringarna som att söka de första patenten, skriva en affärsplan samt göra en marknadsundersökning, kommer förutsättningarna för lyckosamma affärer att öka ännu mer.

innkapNews - May 4, 2007 - InnovationsKapital: Hexaformer expands following investment from InnovationsKapital

2007-05-04 00:00:00

Hexaformer, a Swedish challenger on the global market for distribution transformers, today announced that the leading Nordic private equity/venture capital investment firm, InnovationsKapital, invests 30MSEK in the company. The investment makes it possible to expand sales and production for Hexaformer’s patented distribution transformers. During several years, Hexaformer has worked intensively to develop a new generation transformer, one that is significantly better and cheaper to produce compared to a conventional transformer. Up until now, Hexaformer has primarily sold prototypes, and smaller series of the new transformer – a total of 700 units have been sold to, among others, Vattenfall, Eon, Fortum, and Jämtkraft. “The investment from InnovationsKapital makes it possible to ramp up production and sales, and make an aggressive bet on becoming a leading vendor of distribution transformers to customer all over Europe. A fully automated production line, with an initial capacity of 1,500 transformers per year, is being built in Västervik”, says Magnus Palmstierna, CEO of Hexaformer. ”Hexaformer is a very exciting company with a unique value proposition, a strong patent portfolio, and a great market position in the Nordic countries”, says Martin Falkevall, Investment Director at InnovationsKapital. In connection to the investment from InnovationsKapital, the board of directors will be expanded and strengthened. Sören Swärd will be among those added to the board. Sören has extensive experience from the sector, and formerly served as the CEO of Siemens Sweden AB. “In my previous role as CEO of Siemens Sweden, I followed Hexaformer’s development during an extended period of time. The fact that Hexaformer’s transformers were significantly better than the conventional kind was something that I understood very early. I am now even more convinced about the products superiority, and I am excited to take part in the company’s plans for the future. I hope that my long industrial experience and the network that I have built up over the years will contribute positively to the company’s development going forward”, says Sören Swärd. For more information, please contact: Magnus Palmstierna, CEO, Hexaformer, telephone +46 70 590 15 65, e-mail: magnus.palmstierna@hexaformer.com Mattias Klintemar, CFO, Hexaformer, telephone +46 709 32 64 67, e-mail: mattias.klintemar@hexaformer.com Martin Falkevall, Investment Director, InnovationsKapital, telephone +46 708 47 73 16, e-mail: martin.falkevall@innkap.se About Hexaformer: Hexaformer is a Swedish company developing, manufacturing, and selling the market’s most efficient transformers and reactors. The transformers are covered by a global patent, based on an innovation by Lennart Höglund. Patent applications have also been filed for the company’s reactor solutions. The company is ramping up a large scale, highly automated production in Västervik. The company delivered its first hexatransformer for commercial use in year 2000, and has since delivered about 700 hexatransformers to a variety of customers, including smaller electricity boards, to large demanding customers such as Vattenfall, Eon, Fortum, Scania and Atlas Copco. The company has, up until InnovationsKapital’s investment, been financed by its CEO, Magnus Palmstierna, Bliwa Livförsäkring, Saminvest, and some 20 private investors. For more information, please visit our home page: http://www.hexaformer.com About InnovationsKapital: InnovationsKapital was founded in 1994 and is a leading venture capital firm for innovative growth companies. The business is focused on Nordic investments within Information & Communication Technology (ICT), Healthcare & Life Sciences and Clean Tech – dynamic sectors that are rapidly expanding and where Nordic research plays an important role. InnovationsKapital has invested in over 55 companies, and examples of successful exits are Altitun, Arexis, BioInvent/Alligator, Carmen Systems, Formex, Kreatel, Nordnav and Spotfire. InnovationsKapital currently advises four venture funds aggregating EUR 320 million in committed capital. The capital is provided by international institutional investors. For further information about InnovationsKapital, please visit our home page: http://www.innkap.se

innkapNews - May 3, 2007 - InnovationsKapital: Spotfire acquired for 195 MUSD - InnovationsKapital makes a return on investment of 9X in cash

2007-05-03 00:00:00

The IT company Spotfire has been acquired by TIBCO, a US software company quoted on Nasdaq. As a result of the deal, InnovationsKapital’s first fund, InnKap 1, can now be closed. The performance of this fund has been outstanding with investors receiving a return in excess of 7x on their investment. As a result InnKap 1 has achieved a unique position amongst the very best early stage European venture capital funds of this vintage. Spotfire achieved a return, in cash, of 9X of the investment and for InnovationsKapital, Spotfire is another success story in a line of recent successful investments. During the past year, thriving businesses such as Kreatel, Carmen Systems and Nordnav, have been sold with exceptional returns. “Since we started in 1994, we have completed almost 60 investments and achieved 30 exits. The exit in Carmen Systems last year was awarded “The Exit of The Year”, by both the Swedish Private Equity & Venture Capital Association and Nordic Unqoute. This continues to confirm that our early stage investment strategy is a successful model when the longer term perspective is taken””, says Staffan Ingeborn, CEO of InnovationsKapital and responsible for the investment in Spotfire. Outstanding result in InnKap 1 As a result of the exit in Spotfire, InnovationsKapital’s first fund can now be closed with this outstanding result. Four out of the eighteen investments in the fund have each yielded more than a 9X return on investment. “Those institutions who invested in our fund have received 7X the invested capital in net yield. It places us in a unique position in Europe. It’s exceptional to have so many first-rate investments in the same fund”, says Staffan Ingeborn. From research project to world leading company in ten years Spotfire, which was one of InnovationsKapital’s earlier investments, had its origins in a research project at Chalmers University of Technology which was led by Christopher Ahlberg, the CEO and founder. Today, ten years later, Spotfire is a global leader in its niche segment of the software market, with 7 out of 10 of the largest companies in the world on the customer list. Building for long term success “Many entrepreneurs are interested in an investment partnership with InnovationsKapital but we only invest in companies where we believe that there are good growth prospects on the international market. This proved to be the case for Spotfire, which is now joining our other success stories”, says Staffan Ingeborn. “Besides the necessary capital, InnovationsKapital have contributed with a great deal of experience in building growth companies together with an exceptional network of contacts. They helped us to think and act ‘as a business’ in a long term and focused way. Now, Spotfire is progressing well and is ready to take the next leap forward together with the new shareholders. This means that the business will progress and be further strengthened”, says Christopher Ahlberg, CEO and founder of Spotfire. Searching for “new Spotfires” ”We are on the hunt for new Spotfires. We are currently spending a significant amount of time and effort seeking new early stage high growth companies for InnKap 4, our latest fund. We have already found several very interesting investment opportunities which we believe will have every chance of succeeding, like Spotfire, and we will continue to work on them together with those potential pots of gold which we already have in our portfolio”, says Staffan Ingeborn. Media Enquiries: Staffan Ingeborn, CEO InnovationsKapital +46 (0)70 583 14 34 Advisors to the Investor Consortium and Management: • Financial: Goldman Sachs • Legal: Foley Hoag LLP InnovationsKapital was founded in 1994 and is a leading early stage venture capital firm for innovative growth companies in the Nordic region. The business, carried out from offices in Gothenburg and Stockholm, is focused on Nordic investments within ICT, Healthcare & Life Sciences and Clean Tech – dynamic sectors that are rapidly expanding and where Nordic research plays an important role. InnovationsKapital currently advises four venture funds aggregating EUR 320 million in committed capital. The capital is provided by international institutional investors. For further information, please visit http://www.innkap.se

innkapNews - Mar 22, 2007 - InnovationsKapital: SVCA Awards 2007 - Årets prisbelönade private equity-bolag

2007-03-22 00:00:00

Industri Kapital, Creandum och InnovationsKapital belönades i går på Svenska Riskkapitalföreningens heldagskonferens med utmärkelserna Årets mest samhällsnyttiga investering, Årets kapitalanskaffning respektive Årets exit. Priset för Årets mest samhällsnyttiga investering eller projekt tilldelades Industri Kapital för projektet för bekämpning av sömnsjukan i Uganda. I samarbete med två portföljbolag, myndigheter i Uganda samt universitet i Skottland och Uganda har Industri Kapital bedrivit ett projekt med syftet att stoppa sömnsjukans spridning, och att förhindra mutation till en ny form av sjukdomen. Projektet har på ett innovativt sätt kombinerat Industri Kapitals finansiella resurser och erfarenhet av projekthantering med materiella resurser och specialistkompetens från två av Industri Kapitals portföljbolag. Projektet visar hur positiva resultat kan åstadkommas genom samverkan mellan näringsliv, universitet och myndigheter, även när parterna finns i spridda delar av världen. Övriga nominerade var Procuritas projekt Charity Rating och Swedfunds investering i Addis Cardiac Hospital. Creandum tilldelades SVCA Awards för årets kapitalanskaffning. Creandums team genom förde kapitalanskaffningen till sin andra fond, Creandum II under en för venture-fonder mycket kort tid, 100 dagar. Fonden, om 750 miljoner kronor, är inriktad på teknikbolag i tidiga skeden. Investerarkretsen utökades från de två ursprungliga svenska investerarna till ett flertal välrenommérade institutioner, merparten internationella. Övriga nominerade var fonderna Northzone V och EQT V. InnovationsKapital tilldelades priset för Årets exit för försäljningen av Carmen Systems till Boeing Company. Under InnovationsKapitals sju år som ägare utvecklades Carmen Systems från ett litet venture till ett företag med 300 anställda. Genom att tillföra ett långsiktigt ägarperspektiv, industriell kunskap och ett aktivt ägar engagemang bidrog InnovationsKapital till att utveckla Carmen till en ledande aktör inom sitt segment. Vid försäljningen gjorde InnovationsKapital en vinst på 9 gånger insatt kapital. Övriga nominerade var 3i, InnovationsKapital, SMAC för försäljningen av Nordnav Technologies och Bridgepoint Capital för försäljningen av CarPark. Fotografier av pristagarna finns att ladda ner från http://www.svca.se För mer information, var god kontakta: VD Tom Berggren, (SVCA), 070- 8600 500 eller e-post: tom.berggren@svca.se

innkapNews - Mar 21, 2007 - InnovationsKapital: SVCA Awards 2007 - Årets prisbelönade private equity-bolag

2007-03-21 00:00:00

Industri Kapital, Creandum och InnovationsKapital belönades i går på Svenska Riskkapitalföreningens heldagskonferens med utmärkelserna "Årets mest samhällsnyttiga investering", "Årets kapitalanskaffning" respektive "Årets exit". Priset för Årets mest samhällsnyttiga investering eller projekt tilldelades Industri Kapital för projektet för bekämpning av sömnsjukan i Uganda. I samarbete med två portföljbolag, myndigheter i Uganda samt universitet i Skottland och Uganda har Industri Kapital bedrivit ett projekt med syftet att stoppa sömnsjukans spridning, och att förhindra mutation till en ny form av sjukdomen. Projektet har på ett innovativt sätt kombinerat Industri Kapitals finansiella resurser och erfarenhet av projekthantering med materiella resurser och specialistkompetens från två av Industri Kapitals portföljbolag. Projektet visar hur positiva resultat kan åstadkommas genom samverkan mellan näringsliv, universitet och myndigheter, även när parterna finns i spridda delar av världen. Övriga nominerade var Procuritas projekt Charity Rating och Swedfunds investering i Addis Cardiac Hospital. Creandum tilldelades SVCA Awards för årets kapitalanskaffning. Creandums team genom¬förde kapitalanskaffningen till sin andra fond, Creandum II under en för venture-fonder mycket kort tid, 100 dagar. Fonden, om 750 miljoner kronor, är inriktad på teknikbolag i tidiga skeden. Investerarkretsen utökades från de två ursprungliga svenska investerarna till ett flertal välrenommérade institutioner, merparten internationella. Övriga nominerade var fonderna Northzone V och EQT V. InnovationsKapital tilldelades priset för Årets exit för försäljningen av Carmen Systems till Boeing Company. Under InnovationsKapitals sju år som ägare utvecklades Carmen Systems från ett litet venture till ett företag med 300 anställda. Genom att tillföra ett långsiktigt ägarperspektiv, industriell kunskap och ett aktivt ägar¬¬engagemang bidrog InnovationsKapital till att utveckla Carmen till en ledande aktör inom sitt segment. Vid försäljningen gjorde InnovationsKapital en vinst på 9 gånger insatt kapital. Övriga nominerade var 3i, InnovationsKapital, SMAC för försäljningen av Nordnav Technologies och Bridgepoint Capital för försäljningen av CarPark.

innkapNews - Jan 15, 2007 - InnovationsKapital: Swedish GPS start-up Nordnav sold for $75m

2007-01-15 00:00:00

- World leader in Bluetooth technology, CSR, strengthens its product portfolio through acquisition 3i Group plc, InnovationsKapital and smac partners together with Nordnav’s management, have agreed to sell Nordnav, a Swedish pioneer in next generation GNSS receivers, to Cambridge Silicon Radio (LSE: CSR.L). The purchase price for all shares in the company is approximately $75 million. InnovationsKapital and 3i co-led the first investment round in Nordnav in May 2005. Kimmo Korpela, Director, 3i Nordic, comments on the sale:”This transaction has very clear logic in the industry and is a very good outcome for Nordnav and its shareholders. We, at 3i, are especially delighted to have demonstrated our value by introducing Nordnav to CSR, a highly successful company and originally a 3i investment.” Peder Holm, Investment Director, InnovationsKapital, says: “This is a successful investment that will generate up to 8 times our total investment in the company.” Nordnav, which was founded 2002 by two researches from Luleå University and Stanford University, Per Ludvig Normark and Dennis Akos, is today a market leader in the software GNSS receiver market, providing the only genuinely working GPS software solution for mobile devices. Nordnav develops and licenses software receivers for GPS and Galileo that offer both better performance and significant cost savings compared with alternatives. The company’s solutions enable high quality location functionality to be built into any portable device, including mobile phones, PDAs, and automotive navigation systems. Fredrik Cronqvist, Investment Manager, InnovationsKapital, adds: “We believe that CSR is a great industrial partner that can make a large and successful business out of Nordnav’s world leading GPS technology. This acquisition will enable CSR to provide GPS in mass-market mobile handsets at a significantly lower price compared to competitors.” CSR plc is a world leader in Bluetooth technology, which 3i co-founded as part of a syndicate in 1999 and helped to float on the London Stock Exchange in 2004. Arma Partners has acted as the vendor’s advisor in the transaction. For further information, please contact: Kimmo Korpela, Director, 3i Nordic plc, advisor for 3i Group plc: Tel. +46 8 506 101 44, +46 70 348 88 19 Peder Holm, Investment Director, InnovationsKapital: +46 8 54 50 14 93, +46 703 46 57 70 Fredrik Cronqvist, Investment Manager, InnovationsKapital: +46 8 54 50 14 92, +46 703 13 73 33 Dr. Dietrich Ulmer, Managing Partner, smac partners GmbH: +49 89 55 06 88 11, +49 173 53 45 851 Mattias Åström, Chief Executive Officer, Nordnav Technologies: +46 8 39 0000 About 3i 3i is a world leader in private equity and venture capital. We focus on Buyouts, Growth Capital, Venture Capital and Infrastructure and invest across Europe, the United States and Asia. Our competitive advantage comes from our international network and the strength and breadth of our relationships in business. These underpin the value that we deliver to our portfolio and to our shareholders. http://www.3i.com About InnovationsKapital InnovationsKapital was founded in 1994 and is a private and independent venture capital firm for innovative growth companies. The investment strategy is focused on Nordic investments within ICT and Healthcare & Life Sciences – dynamic sectors that are rapidly expanding and where Nordic research plays an important role. To date, more than 55 investments have been made. Successful exits include Altitun, Arexis, BioInvent/Alligator, Carmen Systems, Formex and Kreatel Communications. InnovationsKapital advises four venture capital funds aggregating EUR 317 million in committed capital. The capital is provided by highly reputable Swedish and international institutional investors. Further information about InnovationsKapital can be found at http://www.innkap.se About smac partners smac partners - formerly known as Siemens Acceleration in Communications - is a private equity company specialised in managing venture portfolios worldwide. We are focused on VC deals in ICT worldwide with an exceptional track record. smac partners offers secondary asset transactions and actively manages the respective portfolio companies. In this role we currently advice TempoPark Fund I. Further information about smac partners can be found at http://www.smacpartners.com About Nordnav Nordnav develops and licenses software receivers for GPS and Galileo that offer both better performance and significant cost savings. Our solution enables high quality location functionality to be built into any device, including mobile phones, PDAs, and digital cameras, as well as into automotive navigation systems. Our products are licensed to leading manufacturers in the mobile, automotive, and consumer electronics industries across the world. Nordnav is headquartered in Stockholm, Sweden. Information about Nordnav can be found at http://www.Nordnav.com

innkapNews - Dec 7, 2006 -InnovationsKapital: Carmen Systems - Venture exit of the year

2006-12-07 00:00:00

InnovationsKapital, together with Gilde Investment Fund and GE Capital, won the Nordic Unquote’s award Venture exit of the year - “an outstanding exit of a Nordic company in the past twelve months. It recognises innovation and clear leadership in the venture market.”

In March 2006, Carmen Systems was sold to The Boeing Company, giving net proceeds to InnovationsKapital of SEK 190 million. InnovationsKapital has in total invested SEK 21 million and makes a return on investment of 9X in cash. Since InnovationsKapital’s investment, Carmen Systems has developed into a leading resource optimization solution provider in the railroad and airline industries. “Carmen is a good example on how InnovationsKapital invests in early stage, technology companies in the Nordic region and supports them to grow globally and enter into the world market. The company has had an impressive development during the years of InnovationsKapitals’ participation. We have seen the company grow from a very small venture to 300 employees. The management has succeeded in turning Carmen into a leading international business in its field,” says Gunnar Fernström, Investment Director at InnovationsKapital. Carmen Systems joined the Jeppesen group of companies within Boeing Commercial Aviation Services (CAS). Carmen Systems AB Carmen Systems develops, markets and implements resource optimization software and services solutions for clients in the transportation industry, primarily the airline and railway industries. Clients include, among others; Aeroméxico, Air France-KLM, British Airways, Delta Air Lines, Finnair, Lufthansa, Scandinavian Airlines, Singapore Airlines, Spanair, Virgin Atlantic Airways, Deutsche Bahn (German Railways), Amtrak, Green Cargo, National Rail Enquiries (UK), RailCorp - New South Wales (Australia) and SNCF (French National Railways). Carmen Systems is a rapidly expanding organization and today has 295 employees from 33 nationalities. Carmen Systems’ headquarters is in Göteborg, Sweden with additional offices in Austin (Texas), Brisbane (Australia), Copenhagen, London, Montreal, Singapore and Stockholm. The Boeing Company Boeing is the world's leading aerospace company and the largest manufacturer of commercial jetliners and military aircraft, with capabilities in rotorcraft, electronic and defense systems, missiles, satellites, launch vehicles and advanced information and communication systems. Our reach extends to customers in 145 countries around the world, and we are the number one U.S. exporter in terms of sales. Jeppesen Jeppesen is recognized as the world's foremost provider of information solutions in the aviation and soon-to-be maritime markets. Jeppesen's portfolio includes: worldwide flight information, flight operations services, international trip planning services, aviation weather services and aviation training systems. Jeppesen's marine division will soon produce a full line of navigation solutions and global maritime data services. Jeppesen has offices in the United States, the United Kingdom, Germany, Australia, China, France and Russia. Jeppesen is a subsidiary of Boeing Commercial Aviation Services, a unit of Boeing Commercial Airplanes.

innkapNews - Oct 9, 2006 - InnovationsKapital: Venture Capital Alive and Kicking: SJ Berwin LLP Advises InnovationsKapital on SEK 1 Billion Venture Fund

2006-10-09 00:00:00

Leading private equity firm SJ Berwin LLP advised established client InnovationsKapital on the raising of its fourth venture fund, InnKap 4 Partners with commitments of around SEK 1 billion. The fund will focus on innovative start-up and early stage growth companies operating in the Nordic region and active in the ICT and Healthcare & Life Sciences market sectors. InnovationsKapital is a well established independent early stage venture capital firm. Since 1994, it has completed 56 investments, earned an excellent reputation and is now a preferred venture capital investor for leading entrepreneurs. InnovationsKapital’s aggregated capital under management now amounts to EUR 317 million. Corporate partner, Richard Watkins, who led the SJ Berwin team, commented: “This fundraising is indicative of the beginning of the resurgence of interest in leading venture capital funds in Europe after a few years of being out of favour. InnovationsKapital has a solid track record and shows that investors will continue to back established and successful European venture capital funds” Staffan Ingeborn, CEO at InnovationsKapital added: We are delighted that InnKap 4 Partners has succeeded in attracting so many respected international investors. We owe this success to the solid support from our loyal long-term investors and are pleased to see so many of them taking part in this new fund,” -ends- For further information please contact: Richard Watkins, Corporate Partner on 020 7111 or by emailing richard.watkins@sjberwin.com Aurelia Pretorius, Business Development Manager on 020 7111 2060 or by emailing aurelia.pretorius@sjberwin.com Notes To Editors Founded in 1982, SJ Berwin is a leading City corporate and commercial law firm with more than 550 lawyers working across its offices in London, Berlin, Brussels, Frankfurt, Madrid, Milan, Munich, Paris and Turin. With more than 200 corporate finance lawyers, the depth and breadth of expertise of our pan-European Corporate Finance Department is considerable. We offer the complete range of corporate finance services, which extends to all aspects of domestic and cross-border M&A and buy-outs, private equity, equity capital markets, financial services and tax. SJ Berwin has a leading secondaries practice with extensive experience - both establishing funds to acquire secondary private equity interests, and in doing the deals themselves. We are delighted to have worked with all the leading secondary players in Europe, including Access Capital Partners, Axa Private Equity, Coller Capital, Goldman Sachs, Greenpark Capital, Headway Capital, Natexis Private Equity Opportunities and Vision Capital, advising on the legal, tax and regulatory issues that arise in the structuring and fundraising process as well as transaction structuring and execution. SJ Berwin was created and thrives as a leading-edge legal services business, focusing on the European and international market place. Our clients are sophisticated buyers of legal services, principally entrepreneurial companies and financial institutions, whom we advise on a comprehensive range of services including Corporate Finance, Commercial, Real Estate, Banking, Reconstruction & Insolvency, Financial Services, Litigation, Employment & Pensions, EU & Competition and Tax. Our approach has resulted in the firm winning a number of recent awards including “Fund Formation Team of the Year” 2006 at the Financial News Awards for Excellence in Private Equity Advisory Services, “Law Firm of the Year 2005 at the EVCA/Real Deals European Private Equity Awards for the second successive year,” European Law Firm of the Year (fund formation) by subscribers to PrivateEquityOnline and Private Equity International, Private Equity Law Firm of the Year 2004 at the European Venture Capital journal awards 2004 and 2005, LBO Firm of the Year 2004 at the Finance and Law Awards in Paris, Real Estate Team of the Year at The Lawyer Awards 2004, and World's Leading Firm for Private Funds Expertise in The International Who's Who of Business Lawyers 2003/4. SJ Berwin LLP was named ‘UK Firm of the Year’ at the 2005 Legal Week Awards on 30th November. 2005 The awards recognised SJ Berwin’s five years of international expansion and its involvement in a series of high quality deals. In April 2005 Head of Private Equity, Jonathan Blake, was named Global Lawyer of the Year in the Private Funds category by The International Who’s Who of Business Lawyers 2004/2005. In November 2004, Jonathan Blake, was admitted to the British Venture Capital Association “Hall of Fame” for his services to the private equity industry over the last 20 years.

innkapNews - Oct 6, 2006 - InnovationsKapital: InnovationsKapital secures SEK 1 billion for new investments

2006-10-06 00:00:00

InnovationsKapital, a well established independent early stage venture capital firm, is pleased to announce the closing of the fourth InnKap fund – InnKap 4 Partners. InnovationsKapital’s aggregated capital under management now amounts to EUR 317 million. As with previous funds, InnKap 4 Partners will focus on investing in innovative start-up and early stage growth companies operating in the Nordic region and active in the ICT and Healthcare & Life Sciences market sectors. Since 1994, InnovationsKapital has completed 56 investments, earned an excellent reputation and is now a preferred venture capital investor for top entrepreneurs. We are delighted that InnKap 4 Partners has succeeded in attracting so many respected international investors. We owe this success to the solid support from our loyal long-term investors and are pleased to see so many of them taking part in this new fund,” says Staffan Ingeborn, Managing Investment Director at InnovationsKapital Nordic Advisors AB. Committed capital of EUR 113 million has been raised from a broad mix of Swedish and international investors, including 70 percent of the total from previous investors. Previous investors include Access Capital Partners, Chalmers University of Technology, The First Swedish National Pension Fund, The Third Swedish National Pension Fund, W Capital and The Wellcome Trust. Among the new investors are BP Pension Fund, DnB NOR, Etera, KLP Insurance and Wega Support. In total, the fund has about twenty investors from Europe and the US, with a majority of commitments coming from non-Swedish funds. “The investors have recognised our attractive market position and consistency in terms of track record and proprietary deal access. With our experience from previous funds, coupled with our close co-operation with portfolio companies and our extensive international network, we will help our portfolio companies expand in the global market,” says Peder Holm, Investment Director in the ICT team at InnovationsKapital. The strong deal flow has been confirmed by two new investments in the fund - Ludesi AB and Action Pharma A/S. Ludesi is a global provider of bioinformatics solutions to the life science industry and Action Pharma is dedicated to the discovery and development of novel drugs with significant therapeutic improvement within organ protection in severe cardiovascular diseases. ”The high quality investors in this fund recognize InnovationsKapital’s ability to identify promising healthcare/life science companies and supply them with access to the scientific, capital and management resources critical for success” says Ulf Tossman, Investment Director in the Healthcare/Life Science team of InnovationsKapital. InnovationsKapital has a solid track record. During 2006, Carmen Systems and Kreatel Communications have been sold successfully to Boeing and Motorola respectively. Gothenburg/Stockholm, October 6, 2006 InnovationsKapital Nordic Advisors AB For further information please contact any of the Investment Directors: Staffan Ingeborn +46 31 60 91 91 +46 705 83 14 34 si@innkap.se Gunnar Fernström +46 31 60 91 92 +46 703 12 05 02 gf@innkap.se Peder Holm +46 8 54 50 14 93 +46 703 46 57 70 ph@innkap.se Jonas Risberg +46 8 54 50 14 95 +46 703 78 17 00 jri@innkap.se Ulf Tossman +46 8 54 50 14 91 +46 705 63 08 58 ut@innkap.se Martin Falkevall +46 8 54 50 14 96 +46 708 47 73 16 mf@innkap.se About InnovationsKaptial InnovationsKapital was founded in 1994 and is a private and independent early stage venture capital firm for innovative growth companies. The business, carried out from offices in Gothenburg and Stockholm, is focused on Nordic investments within ICT and Healthcare & Life Sciences – dynamic sectors that are rapidly expanding and where Nordic research plays an important role. To date, more than 55 investments have made. Successful exits include Altitun, Arexis, BioInvent/Alligator, Carmen Systems, Formex and Kreatel Communications. InnovationsKapital advises four venture capital funds aggregating EUR 317 million in committed capital. The capital is provided by highly reputable Swedish and international institutional investors. Further information about InnovationsKapital can be found at http://www.innkap.se

innkapNews - Sep 20, 2006 -InnovationsKapital: Ludesi accelerates growth through InnKap investment

2006-09-20 00:00:00

September 20, 2006, Lund, Sweden. Ludesi AB, a global provider of bioinformatics solutions to the life science industry, today announced that the leading venture capital firm InnovationsKapital invests SEK 25 million in Ludesi. By this transaction InnovationsKapital will join Ludesi´s current investors FöretagsByggarna and the Sixth AP Fund. The funding will allow Ludesi to roll out sales of Ludesi´s innovative and successful offering for image analysis of 2D electrophoresis gels and to expand the company´s product portfolio into other expression proteomics technologies according to customer demands. Ludesi´s image analysis offering is based on world–leading technology for advanced mathematical imaging and an analysis center performing quality–controlled analysis of 2D electrophoresis gels. By using a proprietary software technology in combination with an expert analysis center, Ludesi customers gain benefits in accuracy, throughput and cost. "We are convinced that Ludesi will become a leading player in the protein expression analysis market. Mr Ola Forsstrom–Olsson and his team have proven that they truly have developed a unique product offering and we look forward to working together with them to continue building a successful company", says Gunnar Fernström, Investment Director at InnovationsKapital. Ludesi was established in 2001 by CEO Ola Forsstrom–Olsson, the winner of Medicon Valley Entrepreneurship Award and nominated for MIT Technology Reviews top 100 list of the world´s best technology entrepreneurs under the age of 35. The company has since the founding developed a strong software technology and business model for 2DGE, a key technology in the growing field of expression proteomics. The company will now roll out sales of a successful first offering as well as expand the company´s product portfolio into other expression proteomics technologies. "InnovationsKapital is the leading biotech investor for growth companies in the Nordic region and their engagement in Ludesi is aligned with our building of a world–leading software company in the field of expression proteomics. We are very pleased to have InnovationsKapital as an investor in Ludesi." comments Ola Forsstrom–Olsson, CEO at Ludesi. For further information, please contact: Ola Forsstrom–Olsson, CEO, Ludesi Phone: +46 46 286 5510 Mobile: +46 708 122 548 E–mail: ola.forsstrom–olsson@ludesi.com Gunnar Fernström, Investment Director, InnovationsKapital Phone: +46 31 60 91 92 Mobile: +46 703 120 502 E–mail: gf@innkap.se About InnovationsKapital InnovationsKapital was founded in 1994 and is a leading early stage venture capital firm for innovative growth companies in the Nordic region. The business, carried out from offices in Gothenburg and Stockholm, is focused on Nordic investments within ICT and Healthcare & Life Sciences – dynamic sectors that are rapidly expanding and where Nordic research plays an important role. InnvationsKapital currently advises four venture funds aggregating more than EUR 300 million in committed capital. The capital is provided by highly reputable Swedish and international institutional investors. Further information about InnovationsKapital can be found at http://www.innkap.se About Ludesi AB Ludesi is a global provider of bioinformatics solutions to the life science industry. The company was established in 2001 and is serving some of the most prestigious research facilities in the world with high–quality image analysis of protein gels. Ludesi´s image analysis service is distributed on the internet, allowing companies to get reliable analysis of 2D electrophoresis gels without spending time and money on 2D gel software. The analysis is performed at the Ludesi Analysis Center with world–leading in–house technology to ensure high quality results. By using a specialized analysis center performing 2D gel image analysis, Ludesi customers gain large–scale benefits in accuracy, throughput and cost. This analysis method is rapidly gaining acceptance as the new way of performing image analysis in 2D gel electrophoresis. More information can be found at http://www.ludesi.com

innkapNews - May 30, 2006 - InnovationsKapital: Martin Falkevall joins InnovationsKapital as a new Investment Director in the Information and Communication Technology sector

2006-05-30 00:00:00

Martin Falkevall has joined InnovationsKapital, one of the leading start-up and early stage venture capitalists in the Nordic region, as an Investment Director in the Information and Communication Technology team based in Stockholm. Martin, who is 36, has 9 years experience in the Nordic venture capital industry. He was previously with Capman Capital Management and with Swedestart Management. He joined Swedestart in 1997 as an Analyst, became a Partner in 2000 and remained with them until they were acquired by Capman in 2002, when he became a Partner at Capman. He has a Bachelor of Science degree in Business Administration and Economics and a Master of Science degree in Engineering Physics, both from Lund University. He has been a venture capitalist investing in the Information and Communication Technology sector since 1997 and, as a result, has gained investment experience of the sector for high growth companies requiring seed, start up, early stage and expansion capital in the Nordic region. Martin brings a unique experience of successful early stage investments in the Information and Communication Technology sector and he compliments our team very well, says Staffan Ingeborn, Managing Investment Director of InnovationsKapital. His experience is an excellent fit with our strategic direction and focus and he will play an important role in our current and future investment growth and value creation. I am delighted to join InnovationsKapital, says Martin Falkevall I have great respect for the business approach and competence InnovationsKapital has developed over the years, with a very strong commitment to their portfolio companies and capital growth. The track record of InnovationsKapital is impressive and I am pleased to be part of the company. InnovationsKapital was founded in 1994 and is one of the Nordic regions leading venture capital firms for innovative early stage high growth companies. The business is focused on investments within Information and Communication Technology and HealthCare & Life Science sectors that are rapidly expanding and where Nordic research plays a leading role. The capital is managed in four funds and is provided by highly reputable Swedish and international institutional investors. Stockholm 30 May 2006 For further information please contact: Staffan Ingeborn, Managing Investment Director InnovationsKapital http://www.innkap.se Phone: + 46 31 60 9191 or + 46 70 583 1434 E-mail: staffan.ingeborn@innkap.se Martin Falkevall, Investment Director InnovationsKapital Phone: +46 708 47 73 16 E-mail: martin.falkevall@innkap.se

innkapNews - Sep 20, 2006 - InnovationsKapital: Ludesi accelerates growth through InnKap investment

2006-01-01 00:00:00

September 20, 2006, Lund, Sweden. Ludesi AB, a global provider of bioinformatics solutions to the life science industry, today announced that the leading venture capital firm InnovationsKapital invests SEK 25 million in Ludesi. By this transaction InnovationsKapital will join Ludesi's current investors FöretagsByggarna and the Sixth AP Fund. The funding will allow Ludesi to roll out sales of Ludesi's innovative and successful offering for image analysis of 2D electrophoresis gels and to expand the company's product portfolio into other expression proteomics technologies according to customer demands. Ludesi's image analysis offering is based on world-leading technology for advanced mathematical imaging and an analysis center performing quality-controlled analysis of 2D electrophoresis gels. By using a proprietary software technology in combination with an expert analysis center, Ludesi customers gain benefits in accuracy, throughput and cost. ”We are convinced that Ludesi will become a leading player in the protein expression analysis market. Mr Ola Forsstrom-Olsson and his team have proven that they truly have developed a unique product offering and we look forward to working together with them to continue building a successful company”, says Gunnar Fernström, Investment Director at InnovationsKapital. Ludesi was established in 2001 by CEO Ola Forsstrom-Olsson, the winner of Medicon Valley Entrepreneurship Award and nominated for MIT Technology Reviews top 100 list of the world's best technology entrepreneurs under the age of 35. The company has since the founding developed a strong software technology and business model for 2DGE, a key technology in the growing field of expression proteomics. The company will now roll out sales of a successful first offering as well as expand the company's product portfolio into other expression proteomics technologies. “InnovationsKapital is the leading biotech investor for growth companies in the Nordic region and their engagement in Ludesi is aligned with our building of a world-leading software company in the field of expression proteomics. We are very pleased to have InnovationsKapital as an investor in Ludesi.” comments Ola Forsstrom-Olsson, CEO at Ludesi. For further information, please contact: Ola Forsstrom-Olsson, CEO, Ludesi Phone: +46 46 286 5510 Mobile: +46 708 122 548 E-mail: ola.forsstrom-olsson@ludesi.com Gunnar Fernström, Investment Director, InnovationsKapital Phone: +46 31 60 91 92 Mobile: +46 703 120 502 E-mail: gf@innkap.se About InnovationsKapital InnovationsKapital was founded in 1994 and is a leading early stage venture capital firm for innovative growth companies in the Nordic region. The business, carried out from offices in Gothenburg and Stockholm, is focused on Nordic investments within ICT and Healthcare & Life Sciences – dynamic sectors that are rapidly expanding and where Nordic research plays an important role. InnvationsKapital currently advises four venture funds aggregating more than EUR 300 million in committed capital. The capital is provided by highly reputable Swedish and international institutional investors. Further information about InnovationsKapital can be found at www.innkap.se About Ludesi AB Ludesi is a global provider of bioinformatics solutions to the life science industry. The company was established in 2001 and is serving some of the most prestigious research facilities in the world with high-quality image analysis of protein gels. Ludesi's image analysis service is distributed on the internet, allowing companies to get reliable analysis of 2D electrophoresis gels without spending time and money on 2D gel software. The analysis is performed at the Ludesi Analysis Center with world-leading in-house technology to ensure high quality results. By using a specialized analysis center performing 2D gel image analysis, Ludesi customers gain large-scale benefits in accuracy, throughput and cost. This analysis method is rapidly gaining acceptance as the new way of performing image analysis in 2D gel electrophoresis. More information can be found at www.ludesi.com

innkapNews - Sep 7, 2005 - InnovationsKapital: Ulf Tossman joins InnovationsKapital as a new Investment Director in the Healthcare & Life Sciences sector

2005-09-07 00:00:00

Ulf Tossman has joined InnovationsKapital, one of the leading start-up and early stage venture capitalists in the Nordic region, as Investment Director in the Healthcare & Life Sciences team. Ulf Tossman is based at the Stockholm office. Ulf Tossman has joined InnovationsKapital from Carnegie Asset Management where he held the position of Senior Portfolio Manager, managing a global life science fund. Prior to this he was Executive Vice President, Global R&D at Fresenius Kabi. He also gained extensive experience in drug development and the commercialisation process as Medical Director of Schering Northern Europe and as Project Director of CNS products at Astra Arcus. Ulf Tossman has a PhD in Pharmacology from the Karolinska Institutet. “Ulf Tossman represents a ‘hard-to-find’ combination of science, business and management experience on an international level and he compliments our team very well”, says Gunnar Fernström, Head of the Life Science team at InnovationsKapital. “His experience is an excellent fit with our strategic direction and focus on Healthcare & Life Science related investments in the Nordic region”. ”I am delighted to join InnovationsKapital”, says Ulf Tossman. “I have great respect for the business approach and competence InnovationsKapital has developed over the years, with a very strong commitment to their portfolio companies and a team-oriented culture. The track record of InnovationsKapital is impressive and I am pleased to be part of the company.” InnovationsKapital was founded in 1994 and is one of the Nordic regions leading venture capital firms for innovative early stage high growth companies. The business is focused on investments within ICT and HealthCare & Life Sciences, dynamic sectors that are rapidly expanding and where Nordic research plays a leading role. The capital is managed in three funds and is provided by highly reputable Swedish and international institutional investors. Stockholm September 7, 2005 For further information please contact: Gunnar Fernström, Investment Director and Head of the Health Care & Life Science team, InnovationsKapital http://www.innkap.se Phone: + 46 31 60 91 90 or + 46 703 12 05 02 E-mail: gunnar.fernstrom@innkap.se Ulf Tossman, Investment Director, InnovationsKapital http://www.innkap.se Phone: +46 8 54 50 14 91 or +46 705 63 08 58 E-mail: ulf.tossman@innkap.se

innkapNews - Aug 22, 2005 - InnovationsKapital: SEB Företagsinvest, 3i Group plc, Industrifonden och Innovationskapital säljer läkemedelsbolaget Arexis till Biovitrum

2005-08-22 00:00:00

Riskkapitalbolagen 3i Group plc, SEB Företagsinvest, Innovationskapital och Industrifonden har tecknat avtal om att sälja sitt portföljbolag, det svenska läkemedelsbolaget Arexis, till Biovitrum. Arexis är ett svenskt bioteknik- och läkemedelsbolag med en omfattande produktportfölj i prekliniska och kliniska faser. Bolaget, som grundades 1999, har sitt säte i Göteborg och är specialiserat på utveckling av läkemedel för behandling av metabola och inflammatoriska sjukdomar, t ex rubbning i fettupptaget, diabetes, hudinflammation och reumatism. Svenska Biovitrum, som är ett av Europas största bioteknikbolag, förvärvar Arexis för en icke offentlig köpesumma. Denna är uppdelad på en initial betalning och ett flertal milstolpar kopplade till ut-vecklingen i Arexis olika projekt. Thomas Pollare Director på 3i Nordic och rådgivare till 3i Group, kommenterar affären: – Det har varit oerhört givande att tillsammans med Arexis starka ledningsgrupp medverka till företagets utveckling. Sedan vår initiala investering 2001, har Arexis utvecklats från forskning till att bli ett företag med en attraktiv portfölj av kliniska projekt. I Biovitrum får Arexis en stark, industriell ägare som kommer att bidra till Arexis fortsatta positiva utveckling. – Det är med stor glädje vi ser att man i den marknad som varit kan bygga ett riskkapitalfinansierat läkemedelsbolag och sedan framgångsrikt sälja det vidare till en så kompetent köpare som Biovitrum, säger Viktor Drvota, ansvarig för Life Science på SEB Företagsinvest. – Försäljningen av Arexis visar på hur framstående forskare kan bygga betydande värden och skapa attraktiva bolag, säger Gunnar Fernström, Investment Director på InnovationsKapital. – Vi ser med stor tillfredställelse på att vårt portföljbolag Arexis nu får möjlighet att fortsätta sin utveckling inom Biovitrum, säger Hedvig Saindrenan, investeringsansvarig på Industrifonden. Att Arexis nu köps upp av ett annat svenskt bolag innebär en förstärkning av den svenska bioteknikbranschen, även i ett internationellt perspektiv. Genom förvärvet av Arexis tillförs Biovitrum ett flertal projekt i nära klinisk utvecklingsfas samt värdefull forsknings- och utvecklingskompetens inom viktiga terapiområden. – Arexis och Biovitrum passar ovanligt bra ihop med avseende på våra prioriterade terapeutiska områden, säger Biovitrums vd Mats Pettersson. Arexis tillför flera intressanta projekt och med våra förenade styrkor har vi allt som krävs för att driva dem till framgångsrik marknadslansering. Ytterligare upplysningar lämnas av Thomas Pollare, Director 3i Nordic och rådgivare till 3i Group plc: tel 0708 10 79 29 Gunnar Fernström, Investment Director på InnovationsKapital: tel 0703 12 05 02 Hedvig Saindrenan, investeringsansvarig Industrifonden: tel 0708 28 82 20 Viktor Drvota, Ansvarig för Life science, SEB Företagsinvest, tel 070 265 7915 Om 3i Group plc 3i är världsledande inom private equity och venture capital och noterat på Londonbörsen (FTSE100 företag). Vi fokuserar på buyouts, growth capital och venture capital och 3i investerar, med hjälp av lokala rådgivare, i Europa, USA och Sydostasien. Våra konkurrensfördelar är vårt internationella nätverk samt styrkan och bredden i 3is relationer med marknaden. Det bidrar till att vi skapar värden för våra portföljbolag och aktieägare. http://www.3i.com/sweden Om SEB Företagsinvest SEB Företagsinvest är Skandinaviska Enskilda bankens (SEB) riskkapitalenhet. Affärsidén är att investera riskkapital genom ett aktivt ägande i tillväxtbolag inom Life Science och teknik. Sedan starten 1995 har SEB Företagsinvest gjort mer än 60 investeringar och 27 exits. http://www.seb.se/foretagsinvest. Om Innovationskapital InnovationsKapital startade sin verksamhet 1994 och är en ledande venture capital aktör med inriktning på investeringar i ett tidigt skede i unga tillväxtföretag i Norden. Verksamheten, som drivs från kontor i Göteborg och Stockholm, är fokuserad på investeringar i Norden inom ICT (information and communication technology) och Healthcare & Life Sciences – dynamiska branscher som växer snabbt och där nordisk forskning spelar en viktig roll. Kapitalet (200 miljoner euro) förvaltas i tre fonder och tillhandahålls av högt ansedda svenska och internationella institutionella investerare. http://www.innkap.se Om Industrifonden Industrifonden erbjuder tillväxtkapital, kompetens och nätverk till framtidsföretag i hela Sverige. Med 25 års verksamhet och ett förvaltat kapital på nära 3,5 miljarder kronor är vi en av de största aktörerna på den svenska riskkapitalmarknaden. Industrifonden investerar i små och medelstora företag i de flesta branscher och är delägare i elva regionala riskkapitalbolag runt om i Sverige samt i Innovationsbron AB. Industrifonden investerade i Arexis år 2000. http://www.industrifonden.se